JP2013532692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532692A5 JP2013532692A5 JP2013522013A JP2013522013A JP2013532692A5 JP 2013532692 A5 JP2013532692 A5 JP 2013532692A5 JP 2013522013 A JP2013522013 A JP 2013522013A JP 2013522013 A JP2013522013 A JP 2013522013A JP 2013532692 A5 JP2013532692 A5 JP 2013532692A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- carbonyl
- piperidin
- piperidine
- picolinamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 252
- 150000001875 compounds Chemical class 0.000 claims description 134
- -1 methoxy, ethoxy Chemical group 0.000 claims description 100
- 150000003839 salts Chemical class 0.000 claims description 50
- 239000012453 solvate Substances 0.000 claims description 43
- 150000001204 N-oxides Chemical class 0.000 claims description 42
- 229910052799 carbon Inorganic materials 0.000 claims description 23
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 23
- 125000004122 cyclic group Chemical group 0.000 claims description 22
- 125000001188 haloalkyl group Chemical group 0.000 claims description 22
- 229910052736 halogen Inorganic materials 0.000 claims description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 201000010099 disease Diseases 0.000 claims description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
- 125000001072 heteroaryl group Chemical group 0.000 claims description 14
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 125000005549 heteroarylene group Chemical group 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000000732 arylene group Chemical group 0.000 claims description 7
- 208000006011 Stroke Diseases 0.000 claims description 6
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 5
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 5
- 229940106189 ceramide Drugs 0.000 claims description 5
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 5
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 102000004201 Ceramidases Human genes 0.000 claims description 4
- 108090000751 Ceramidases Proteins 0.000 claims description 4
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims description 4
- 206010019280 Heart failures Diseases 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 208000028867 ischemia Diseases 0.000 claims description 4
- 125000002950 monocyclic group Chemical group 0.000 claims description 4
- 125000006578 monocyclic heterocycloalkyl group Chemical group 0.000 claims description 4
- 206010007559 Cardiac failure congestive Diseases 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 230000002503 metabolic effect Effects 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 208000011580 syndromic disease Diseases 0.000 claims description 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 claims description 2
- ISSLZKSSYLRMSG-JDXGNMNLSA-N 5-[(3S,4S)-4-(4-cyanophenoxy)-3-fluoropiperidine-1-carbonyl]-N-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound O([C@H]1CCN(C[C@@H]1F)C(=O)C=1C=NC(=CC=1)C(=O)NC1CCN(CC=2C=CC(=CC=2)C#N)CC1)C1=CC=C(C#N)C=C1 ISSLZKSSYLRMSG-JDXGNMNLSA-N 0.000 claims description 2
- KMRPXMWIZLSCAG-IZZNHLLZSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[(3s,4r)-3-fluoro-1-(pyridin-4-ylmethyl)piperidin-4-yl]pyridine-2-carboxamide Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)F)N1CC1=CC=NC=C1 KMRPXMWIZLSCAG-IZZNHLLZSA-N 0.000 claims description 2
- SSXKELDQHCLBAC-VQTJNVASSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[(3s,4r)-3-fluoropiperidin-4-yl]pyridine-2-carboxamide Chemical compound F[C@H]1CNCC[C@H]1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 SSXKELDQHCLBAC-VQTJNVASSA-N 0.000 claims description 2
- 206010002383 Angina Pectoris Diseases 0.000 claims description 2
- 201000001320 Atherosclerosis Diseases 0.000 claims description 2
- WSHUFJLKIMPHGV-FQLXRVMXSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)N[C@@H]4CCN(C[C@H]4F)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)N[C@@H]4CCN(C[C@H]4F)CC5=CC=C(C=C5)C#N WSHUFJLKIMPHGV-FQLXRVMXSA-N 0.000 claims description 2
- ODBQSZFTJYTYMN-FQLXRVMXSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)N[C@@H]4CCN(C[C@H]4F)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)N[C@@H]4CCN(C[C@H]4F)CC5=CC=C(C=C5)C#N ODBQSZFTJYTYMN-FQLXRVMXSA-N 0.000 claims description 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims description 2
- 206010012289 Dementia Diseases 0.000 claims description 2
- 229920002527 Glycogen Polymers 0.000 claims description 2
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 claims description 2
- 206010022562 Intermittent claudication Diseases 0.000 claims description 2
- 208000010428 Muscle Weakness Diseases 0.000 claims description 2
- 206010028372 Muscular weakness Diseases 0.000 claims description 2
- 208000036572 Myoclonic epilepsy Diseases 0.000 claims description 2
- 208000002033 Myoclonus Diseases 0.000 claims description 2
- 206010053648 Vascular occlusion Diseases 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 208000008445 altitude sickness Diseases 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 201000009028 early myoclonic encephalopathy Diseases 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 230000004190 glucose uptake Effects 0.000 claims description 2
- 229940096919 glycogen Drugs 0.000 claims description 2
- 208000021156 intermittent vascular claudication Diseases 0.000 claims description 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims description 2
- 208000010125 myocardial infarction Diseases 0.000 claims description 2
- XSTWHJANPVSKRP-FQLXRVMXSA-N n-[(3r,4r)-1-[(4-cyano-3-fluorophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=C(F)C(C#N)=CC=3)CC2)F)CC1 XSTWHJANPVSKRP-FQLXRVMXSA-N 0.000 claims description 2
- BFKLKEDGPVUXEU-VSGBNLITSA-N n-[(3r,4r)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-[4-(trifluoromethylsulfonyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C([C@H]([C@@H](CC1)NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C(F)(F)F)F)N1CC1=CC=C(C#N)C=C1 BFKLKEDGPVUXEU-VSGBNLITSA-N 0.000 claims description 2
- MWVAIOSVWVODAN-VSGBNLITSA-N n-[(3r,4r)-3-fluoro-1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-5-[4-(4-methylsulfonylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)F)CC1 MWVAIOSVWVODAN-VSGBNLITSA-N 0.000 claims description 2
- QYKFEEHGZRXLOV-VSGBNLITSA-N n-[(3r,4r)-3-fluoro-1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-5-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)F)CC1 QYKFEEHGZRXLOV-VSGBNLITSA-N 0.000 claims description 2
- QFCGCJFUXOLOOW-RRPNLBNLSA-N n-[(3s,4r)-1-[(4-chlorophenyl)methyl]-3-fluoropiperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)F)N1CC1=CC=C(Cl)C=C1 QFCGCJFUXOLOOW-RRPNLBNLSA-N 0.000 claims description 2
- QECRHJAQOQEILO-IZZNHLLZSA-N n-[(3s,4r)-3-fluoro-1-[(2-methyl-1,3-thiazol-4-yl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@H](CN(CC=3N=C(C)SC=3)CC2)F)CC1 QECRHJAQOQEILO-IZZNHLLZSA-N 0.000 claims description 2
- HJLLFICFQXAIAT-IZZNHLLZSA-N n-[(3s,4r)-3-fluoro-1-[(5-methyl-1,2-oxazol-3-yl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@H](CN(CC3=NOC(C)=C3)CC2)F)CC1 HJLLFICFQXAIAT-IZZNHLLZSA-N 0.000 claims description 2
- LEUSDRGCPVXECX-VMPREFPWSA-N n-[(3s,4s)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@@H]2[C@H](CN(CC=3C=CC(=CC=3)C#N)CC2)F)CC1 LEUSDRGCPVXECX-VMPREFPWSA-N 0.000 claims description 2
- FKPPDDDQZXPHNG-UHFFFAOYSA-N n-[1-[(3-fluoro-4-methoxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=C(F)C(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 FKPPDDDQZXPHNG-UHFFFAOYSA-N 0.000 claims description 2
- 230000008816 organ damage Effects 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 230000037361 pathway Effects 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 2
- 208000021331 vascular occlusion disease Diseases 0.000 claims description 2
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 3
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- 208000010444 Acidosis Diseases 0.000 claims 1
- 206010003591 Ataxia Diseases 0.000 claims 1
- 206010048804 Kearns-Sayre syndrome Diseases 0.000 claims 1
- 208000006136 Leigh Disease Diseases 0.000 claims 1
- 208000017507 Leigh syndrome Diseases 0.000 claims 1
- 208000029578 Muscle disease Diseases 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 230000007950 acidosis Effects 0.000 claims 1
- 208000026545 acidosis disease Diseases 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000004351 coronary vessel Anatomy 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 230000002438 mitochondrial effect Effects 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 claims 1
- 238000000034 method Methods 0.000 description 50
- 239000000126 substance Substances 0.000 description 45
- 239000000203 mixture Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 16
- 0 C*[C@](C)(*)N=*C Chemical compound C*[C@](C)(*)N=*C 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000012902 Nervous system disease Diseases 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- GJHZOKKWVMPWMH-UHFFFAOYSA-N 2-N-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2,5-dicarboxamide Chemical compound N1=C(C=CC(=C1)C(=O)N)C(=O)NC1CCN(CC1)CC1=CC=C(C=C1)C#N GJHZOKKWVMPWMH-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KILULKZXXSWNCI-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-(4-fluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 KILULKZXXSWNCI-UHFFFAOYSA-N 0.000 description 2
- BZCVQNXMJJLXPG-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 BZCVQNXMJJLXPG-UHFFFAOYSA-N 0.000 description 2
- QVGHVUBOGYEDKB-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 QVGHVUBOGYEDKB-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000004065 mitochondrial dysfunction Effects 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 230000004137 sphingolipid metabolism Effects 0.000 description 2
- BKCJRBLXKYEYHK-UHFFFAOYSA-N 1-[(4-cyanophenyl)methyl]-n-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]piperidine-4-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC(=O)C3CCN(CC=4C=CC(=CC=4)C#N)CC3)=CC=2)CC1 BKCJRBLXKYEYHK-UHFFFAOYSA-N 0.000 description 1
- GFDOYTAWIKLKSA-UHFFFAOYSA-N 2-n,5-n-bis(1-benzylpiperidin-4-yl)pyridine-2,5-dicarboxamide Chemical compound C=1C=C(C(=O)NC2CCN(CC=3C=CC=CC=3)CC2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 GFDOYTAWIKLKSA-UHFFFAOYSA-N 0.000 description 1
- ZNLOQOLMQYQXNI-UHFFFAOYSA-N 2-n,6-n-bis[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2,6-dicarboxamide Chemical compound C=1C=CC(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 ZNLOQOLMQYQXNI-UHFFFAOYSA-N 0.000 description 1
- RKTWPHQFWGVWFF-UHFFFAOYSA-N 2-n,6-n-bis[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-2,6-dicarboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2N=C(C=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 RKTWPHQFWGVWFF-UHFFFAOYSA-N 0.000 description 1
- CWIOPRLBOMZPKA-UHFFFAOYSA-N 2-n-(1-benzylpiperidin-4-yl)-5-n-(4-phenylphenyl)pyridine-2,5-dicarboxamide Chemical compound C=1C=C(C(=O)NC2CCN(CC=3C=CC=CC=3)CC2)N=CC=1C(=O)NC(C=C1)=CC=C1C1=CC=CC=C1 CWIOPRLBOMZPKA-UHFFFAOYSA-N 0.000 description 1
- PYLAIZRZOYDMDH-UHFFFAOYSA-N 2-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-n-[1-(4-cyanophenyl)piperidin-4-yl]pyridine-2,5-dicarboxamide Chemical compound C=1C=C(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)N=CC=1C(=O)NC(CC1)CCN1C1=CC=C(C#N)C=C1 PYLAIZRZOYDMDH-UHFFFAOYSA-N 0.000 description 1
- DENRPACRNJYZDG-UHFFFAOYSA-N 2-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-n-[2-(4-fluorophenoxy)ethyl]pyridine-2,5-dicarboxamide Chemical compound C1=CC(F)=CC=C1OCCNC(=O)C1=CC=C(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)N=C1 DENRPACRNJYZDG-UHFFFAOYSA-N 0.000 description 1
- NAUIMQDUCLBJRJ-UHFFFAOYSA-N 2-n-[2-[(4-cyanophenyl)methyl]-3,4-dihydro-1h-isoquinolin-7-yl]-5-n-[(4-fluorophenyl)methyl]pyridine-2,5-dicarboxamide Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=CC=C(C(=O)NC=2C=C3CN(CC=4C=CC(=CC=4)C#N)CCC3=CC=2)N=C1 NAUIMQDUCLBJRJ-UHFFFAOYSA-N 0.000 description 1
- PTNAVJCDQOQYQW-BXWFABGCSA-N 4-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[2-[2-[2-(3-amino-3-oxopropoxy)ethoxy]ethoxy]ethoxy]ethyl]butanamide Chemical compound NC(=O)CCOCCOCCOCCOCCNC(=O)CCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12 PTNAVJCDQOQYQW-BXWFABGCSA-N 0.000 description 1
- HJQDYLZIUZAGJL-UHFFFAOYSA-N 4-[(4-fluorophenyl)methyl]piperazine-1-carbaldehyde Chemical compound C1=CC(F)=CC=C1CN1CCN(C=O)CC1 HJQDYLZIUZAGJL-UHFFFAOYSA-N 0.000 description 1
- BWGZBBSRFIGRTF-UHFFFAOYSA-N 4-[1-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]piperidin-4-yl]oxybenzonitrile Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 BWGZBBSRFIGRTF-UHFFFAOYSA-N 0.000 description 1
- OLOFHQKCBQKIAJ-UHFFFAOYSA-N 4-[[2-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]-2,8-diazaspiro[4.5]decan-8-yl]methyl]benzonitrile Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)N2CC3(CC2)CCN(CC=2C=CC(=CC=2)C#N)CC3)CC1 OLOFHQKCBQKIAJ-UHFFFAOYSA-N 0.000 description 1
- AUSCOAAXXZHOLH-UHFFFAOYSA-N 4-[[4-[[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]amino]piperidin-1-yl]methyl]benzonitrile Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC3CCN(CC=4C=CC(=CC=4)C#N)CC3)=CC=2)CC1 AUSCOAAXXZHOLH-UHFFFAOYSA-N 0.000 description 1
- GUOFMHPMAHVMLC-UHFFFAOYSA-N 4-[[8-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carbonyl]-2,8-diazaspiro[4.5]decan-2-yl]methyl]benzonitrile Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N2CCC3(CN(CC=4C=CC(=CC=4)C#N)CC3)CC2)CC1 GUOFMHPMAHVMLC-UHFFFAOYSA-N 0.000 description 1
- UZKLXKCSYXORTD-UHFFFAOYSA-N 5-(4-benzoylpiperazine-1-carbonyl)-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C(=O)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 UZKLXKCSYXORTD-UHFFFAOYSA-N 0.000 description 1
- ZTXYRALKNNXSHH-UHFFFAOYSA-N 5-(4-benzylanilino)-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=CC(CC=3C=CC=CC=3)=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 ZTXYRALKNNXSHH-UHFFFAOYSA-N 0.000 description 1
- TUXSVDQMBSARPI-UHFFFAOYSA-N 5-(4-benzylpiperazin-1-yl)-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(N2CCN(CC=3C=CC=CC=3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 TUXSVDQMBSARPI-UHFFFAOYSA-N 0.000 description 1
- OQMKCTWXRSKXFX-UHFFFAOYSA-N 5-(4-benzylpiperazine-1-carbonyl)-n-(1-benzylpiperidin-4-yl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CC=CC=3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 OQMKCTWXRSKXFX-UHFFFAOYSA-N 0.000 description 1
- UHPFGVZAKOCMFD-UHFFFAOYSA-N 5-(4-benzylpiperidine-1-carbonyl)-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC=3C=CC=CC=3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 UHPFGVZAKOCMFD-UHFFFAOYSA-N 0.000 description 1
- JZOSWLKELUSKPW-SANMLTNESA-N 5-[(3s)-3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2C[C@H](CC2)OC=2C=CC(F)=CC=2)CC1 JZOSWLKELUSKPW-SANMLTNESA-N 0.000 description 1
- HVGKNJVYYFTFOB-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)-8-azabicyclo[3.2.1]octane-8-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2C3CCC2CC(C3)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 HVGKNJVYYFTFOB-UHFFFAOYSA-N 0.000 description 1
- OALQOHPDGYLZQW-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)azetidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CC(C2)OC=2C=CC(=CC=2)C#N)=C1 OALQOHPDGYLZQW-UHFFFAOYSA-N 0.000 description 1
- WKWOWUPNJQOYOV-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)azetidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CC(C2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WKWOWUPNJQOYOV-UHFFFAOYSA-N 0.000 description 1
- JGBMPZMXPFSPDG-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)azetidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CC(C2)OC=2C=CC(=CC=2)C#N)C=N1 JGBMPZMXPFSPDG-UHFFFAOYSA-N 0.000 description 1
- PYKNAWSLPPFUNW-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(N2CC(CCC2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 PYKNAWSLPPFUNW-UHFFFAOYSA-N 0.000 description 1
- WJFHULPMCHGBBX-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CC(CCC2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WJFHULPMCHGBBX-UHFFFAOYSA-N 0.000 description 1
- BYINZUBHGSJUSR-UHFFFAOYSA-N 5-[3-(4-cyanophenyl)-6,8-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrazine-7-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CC=3N(C(=NN=3)C=3C=CC(=CC=3)C#N)CC2)=C1 BYINZUBHGSJUSR-UHFFFAOYSA-N 0.000 description 1
- NFXJMTPKKPWDFD-UHFFFAOYSA-N 5-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyrazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CN=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)C=N1 NFXJMTPKKPWDFD-UHFFFAOYSA-N 0.000 description 1
- DLBGZVFJKSQFKW-UHFFFAOYSA-N 5-[4-(3,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=C(F)C(F)=CC=2)=C1 DLBGZVFJKSQFKW-UHFFFAOYSA-N 0.000 description 1
- DTDPXJTYCFTEEW-UHFFFAOYSA-N 5-[4-(3,4-difluorophenoxy)piperidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=C(F)C(F)=CC=2)=C1 DTDPXJTYCFTEEW-UHFFFAOYSA-N 0.000 description 1
- FGBIWVHUOKXSKR-UHFFFAOYSA-N 5-[4-(3-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=C(C=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 FGBIWVHUOKXSKR-UHFFFAOYSA-N 0.000 description 1
- CZJQSTWTDOMTMC-UHFFFAOYSA-N 5-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-2-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 CZJQSTWTDOMTMC-UHFFFAOYSA-N 0.000 description 1
- CGANLALLTGBPTO-UHFFFAOYSA-N 5-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CGANLALLTGBPTO-UHFFFAOYSA-N 0.000 description 1
- UGQQVZAGWFGYST-UHFFFAOYSA-N 5-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 UGQQVZAGWFGYST-UHFFFAOYSA-N 0.000 description 1
- JVERBNBWKSQTRY-UHFFFAOYSA-N 5-[4-(4-chlorobenzoyl)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 JVERBNBWKSQTRY-UHFFFAOYSA-N 0.000 description 1
- VHMVZBCHWOEJTQ-UHFFFAOYSA-N 5-[4-(4-cyano-2-methoxyphenoxy)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound COC1=CC(C#N)=CC=C1OC1CCN(C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 VHMVZBCHWOEJTQ-UHFFFAOYSA-N 0.000 description 1
- KKQGVOSIFWFJDK-UHFFFAOYSA-N 5-[4-(4-cyano-2-methoxyphenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound COC1=CC(C#N)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 KKQGVOSIFWFJDK-UHFFFAOYSA-N 0.000 description 1
- KESKUMQAYVXYTP-UHFFFAOYSA-N 5-[4-(4-cyanobenzoyl)piperidine-1-carbonyl]-N-[4-(4-fluorophenoxy)cyclohexyl]pyridine-2-carboxamide Chemical compound Fc1ccc(OC2CCC(CC2)NC(=O)c2ccc(cn2)C(=O)N2CCC(CC2)C(=O)c2ccc(cc2)C#N)cc1 KESKUMQAYVXYTP-UHFFFAOYSA-N 0.000 description 1
- RMRAPVQTYURKPZ-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(N2CCC(CC2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 RMRAPVQTYURKPZ-UHFFFAOYSA-N 0.000 description 1
- IJCLQUTZPNXGSE-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-N-[4-[4-(trifluoromethyl)phenoxy]cyclohexyl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 IJCLQUTZPNXGSE-UHFFFAOYSA-N 0.000 description 1
- SGEPABNOVNCCBC-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)=C1 SGEPABNOVNCCBC-UHFFFAOYSA-N 0.000 description 1
- BPMMMRKHRUQAAY-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 BPMMMRKHRUQAAY-UHFFFAOYSA-N 0.000 description 1
- ZSPDVYPDGBHLED-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[2-(4-fluorophenoxy)ethyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OCCNC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)C=N1 ZSPDVYPDGBHLED-UHFFFAOYSA-N 0.000 description 1
- XZNBTHWUHWCAHY-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[4-(4-fluorophenoxy)cyclohexyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 XZNBTHWUHWCAHY-UHFFFAOYSA-N 0.000 description 1
- YUSQDVWUKSSAEC-UHFFFAOYSA-N 5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(F)=CC=2)CC1 YUSQDVWUKSSAEC-UHFFFAOYSA-N 0.000 description 1
- GQLHMTROMKDTKQ-UHFFFAOYSA-N 5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(F)=CC=2)CC1 GQLHMTROMKDTKQ-UHFFFAOYSA-N 0.000 description 1
- CIXKEBBNLUBQNZ-UHFFFAOYSA-N 5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 CIXKEBBNLUBQNZ-UHFFFAOYSA-N 0.000 description 1
- QJSNZYYRFPKWGV-UHFFFAOYSA-N 5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-N-[4-(4-methoxyphenoxy)phenyl]pyridine-2-carboxamide Chemical compound COc1ccc(Oc2ccc(NC(=O)c3ccc(cn3)C(=O)N3CCC(CC3)C(=O)c3ccc(OC)cc3)cc2)cc1 QJSNZYYRFPKWGV-UHFFFAOYSA-N 0.000 description 1
- SWQOOGAKPQTEBM-UHFFFAOYSA-N 5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-N-[4-[4-(trifluoromethyl)phenoxy]cyclohexyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 SWQOOGAKPQTEBM-UHFFFAOYSA-N 0.000 description 1
- SHXRZVBBZQBCEM-UHFFFAOYSA-N 5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]-N-[4-[4-(trifluoromethyl)phenoxy]cyclohexyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 SHXRZVBBZQBCEM-UHFFFAOYSA-N 0.000 description 1
- NTWQKRFJFGQARC-UHFFFAOYSA-N 5-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)N3CCCC3)CC2)CC1 NTWQKRFJFGQARC-UHFFFAOYSA-N 0.000 description 1
- GAPLEWRIBFUXRK-UHFFFAOYSA-N 5-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)CC1 GAPLEWRIBFUXRK-UHFFFAOYSA-N 0.000 description 1
- UFEIEYBIRIUWRQ-UHFFFAOYSA-N 5-[4-(benzenesulfonyl)piperazine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)S(=O)(=O)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 UFEIEYBIRIUWRQ-UHFFFAOYSA-N 0.000 description 1
- ZSDOZPPRAYGYEU-UHFFFAOYSA-N 5-[4-[(4-cyanophenyl)methyl]piperazine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ZSDOZPPRAYGYEU-UHFFFAOYSA-N 0.000 description 1
- MRMDURIHTGUZQI-UHFFFAOYSA-N 5-[4-[(4-cyanophenyl)methyl]piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC=3C=CC(=CC=3)C#N)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 MRMDURIHTGUZQI-UHFFFAOYSA-N 0.000 description 1
- HQTGOKGRHCNFPD-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(1-phenylpiperidin-4-yl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)C=2C=CC=CC=2)CC1 HQTGOKGRHCNFPD-UHFFFAOYSA-N 0.000 description 1
- DKZIWVLUHXKRHI-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(2-phenylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C(=CC=CC=2)C=2C=CC=CC=2)CC1 DKZIWVLUHXKRHI-UHFFFAOYSA-N 0.000 description 1
- CQQMMXMEYNOOTM-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(3-phenoxyphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=C(OC=3C=CC=CC=3)C=CC=2)CC1 CQQMMXMEYNOOTM-UHFFFAOYSA-N 0.000 description 1
- DEAYGZRRXFNGTA-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(3-phenylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=C(C=CC=2)C=2C=CC=CC=2)CC1 DEAYGZRRXFNGTA-UHFFFAOYSA-N 0.000 description 1
- VHXPMMSGAZXAOF-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-morpholin-4-ylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)N2CCOCC2)CC1 VHXPMMSGAZXAOF-UHFFFAOYSA-N 0.000 description 1
- KFWUZHLIUCMOPR-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-phenoxyphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=CC=CC=3)=CC=2)CC1 KFWUZHLIUCMOPR-UHFFFAOYSA-N 0.000 description 1
- IKKVPXFGSRKNJV-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-phenylmethoxyphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OCC=3C=CC=CC=3)=CC=2)CC1 IKKVPXFGSRKNJV-UHFFFAOYSA-N 0.000 description 1
- PRJISZJJPGFGHG-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-phenylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C=2C=CC=CC=2)CC1 PRJISZJJPGFGHG-UHFFFAOYSA-N 0.000 description 1
- BJRZKIVEUFLPAU-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-thiophen-3-ylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C2=CSC=C2)CC1 BJRZKIVEUFLPAU-UHFFFAOYSA-N 0.000 description 1
- OTTMHRBJZANTRA-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-(1-phenylethyl)piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=CC=CC=1C(C)N(CC1)CCC1NC(=O)C(N=C1)=CC=C1C(=O)N(CC1)CCN1CC1=CC=C(F)C=C1 OTTMHRBJZANTRA-UHFFFAOYSA-N 0.000 description 1
- JBOAVLPHPAENSA-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 JBOAVLPHPAENSA-UHFFFAOYSA-N 0.000 description 1
- ANLDAUPWGMIDKB-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(1h-pyrrol-3-yl)phenyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C2=CNC=C2)CC1 ANLDAUPWGMIDKB-UHFFFAOYSA-N 0.000 description 1
- WDGGQCRMJXHVAD-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(3-methoxyphenoxy)phenyl]pyridine-2-carboxamide Chemical compound COC1=CC=CC(OC=2C=CC(NC(=O)C=3N=CC(=CC=3)C(=O)N3CCN(CC=4C=CC(F)=CC=4)CC3)=CC=2)=C1 WDGGQCRMJXHVAD-UHFFFAOYSA-N 0.000 description 1
- CBGKMLBDMVQWBH-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(3-methylphenoxy)phenyl]pyridine-2-carboxamide Chemical compound CC1=CC=CC(OC=2C=CC(NC(=O)C=3N=CC(=CC=3)C(=O)N3CCN(CC=4C=CC(F)=CC=4)CC3)=CC=2)=C1 CBGKMLBDMVQWBH-UHFFFAOYSA-N 0.000 description 1
- RDGQWELXIWGGAA-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(4-methoxyphenoxy)phenyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 RDGQWELXIWGGAA-UHFFFAOYSA-N 0.000 description 1
- DVMILXSBZSNOPF-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(4-methoxyphenyl)phenyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(C=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 DVMILXSBZSNOPF-UHFFFAOYSA-N 0.000 description 1
- RMWNMWQMKJQMNP-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(4-methylphenoxy)phenyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 RMWNMWQMKJQMNP-UHFFFAOYSA-N 0.000 description 1
- GAYRGESOQUQOTJ-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(4-nitrophenyl)phenyl]pyridine-2-carboxamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(C=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 GAYRGESOQUQOTJ-UHFFFAOYSA-N 0.000 description 1
- RBSXAXHVCUKMIZ-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-[4-(trifluoromethyl)phenyl]phenyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C=2C=CC(=CC=2)C(F)(F)F)CC1 RBSXAXHVCUKMIZ-UHFFFAOYSA-N 0.000 description 1
- AUDCQJXZPQEOHW-UHFFFAOYSA-N 5-[[1-(4-chlorophenyl)piperidin-4-yl]amino]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1N1CCC(NC=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 AUDCQJXZPQEOHW-UHFFFAOYSA-N 0.000 description 1
- OOEKCGKFHYHSPV-UHFFFAOYSA-N 6-(4-benzylpiperazine-1-carbonyl)-n-(1-benzylpiperidin-4-yl)pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CC=CC=3)CC2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 OOEKCGKFHYHSPV-UHFFFAOYSA-N 0.000 description 1
- FXHBRSQJDSUPGH-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[1-[(4-methylsulfonylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)CC1 FXHBRSQJDSUPGH-UHFFFAOYSA-N 0.000 description 1
- PLFKPSQUHVQKGD-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[1-[[4-(methanesulfonamido)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)CC1 PLFKPSQUHVQKGD-UHFFFAOYSA-N 0.000 description 1
- MMDHXUCOBFMXDW-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)N=C1 MMDHXUCOBFMXDW-UHFFFAOYSA-N 0.000 description 1
- YJVUDJAYUHJDRZ-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[6-(4-methylsulfonylphenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)N=C1 YJVUDJAYUHJDRZ-UHFFFAOYSA-N 0.000 description 1
- CSMZDTSEHGVTML-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[6-[4-(dimethylcarbamoyl)phenoxy]pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)N=C1 CSMZDTSEHGVTML-UHFFFAOYSA-N 0.000 description 1
- GUJSBGWSDRFUAC-UHFFFAOYSA-N 6-[4-(2,4-difluorophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C(=CC(F)=CC=2)F)N=C1 GUJSBGWSDRFUAC-UHFFFAOYSA-N 0.000 description 1
- YBCMWZLNHLQBTF-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound CC(=O)NC1=CC=CC(OC2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=C1 YBCMWZLNHLQBTF-UHFFFAOYSA-N 0.000 description 1
- QAQJNUIVHQIXNU-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound CC(=O)NC1=CC=CC(OC2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)=C1 QAQJNUIVHQIXNU-UHFFFAOYSA-N 0.000 description 1
- UFIJHORMJXQIKW-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=C(NC(C)=O)C=CC=2)CC1 UFIJHORMJXQIKW-UHFFFAOYSA-N 0.000 description 1
- HJAZSWLXYPIMTM-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound CC(=O)NC1=CC=CC(OC2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)=C1 HJAZSWLXYPIMTM-UHFFFAOYSA-N 0.000 description 1
- HFTJORLORZXKEZ-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound CC(=O)NC1=CC=CC(OC2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)=C1 HFTJORLORZXKEZ-UHFFFAOYSA-N 0.000 description 1
- GNMBIYXIFWVHBU-UHFFFAOYSA-N 6-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 GNMBIYXIFWVHBU-UHFFFAOYSA-N 0.000 description 1
- YQMZZWAQXKEZOB-UHFFFAOYSA-N 6-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 YQMZZWAQXKEZOB-UHFFFAOYSA-N 0.000 description 1
- XYVPQYHJOMNWFW-UHFFFAOYSA-N 6-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(NC(C)=O)=CC=2)CC1 XYVPQYHJOMNWFW-UHFFFAOYSA-N 0.000 description 1
- NXUARYUTSSUSSG-UHFFFAOYSA-N 6-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)CC1 NXUARYUTSSUSSG-UHFFFAOYSA-N 0.000 description 1
- ACJLYGUYLHGBRM-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridazine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ACJLYGUYLHGBRM-UHFFFAOYSA-N 0.000 description 1
- VPANDGDZYUHJNA-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 VPANDGDZYUHJNA-UHFFFAOYSA-N 0.000 description 1
- KSGRCIGWEWONAI-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 KSGRCIGWEWONAI-UHFFFAOYSA-N 0.000 description 1
- RKZZIRZVMZFRAJ-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[4-(4-cyanophenoxy)cyclohexyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 RKZZIRZVMZFRAJ-UHFFFAOYSA-N 0.000 description 1
- PCKCBYIEMJBCQJ-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 PCKCBYIEMJBCQJ-UHFFFAOYSA-N 0.000 description 1
- NSZYFVPQFQAZIY-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridazine-3-carboxamide Chemical compound C=1C=C(N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 NSZYFVPQFQAZIY-UHFFFAOYSA-N 0.000 description 1
- MZHVANYWYUEJSQ-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-(1,3-oxazol-4-ylmethyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCN1CC1=COC=N1 MZHVANYWYUEJSQ-UHFFFAOYSA-N 0.000 description 1
- AMGOYODSYQCBIL-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-(4-cyanophenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCN1C1=CC=C(C#N)C=C1 AMGOYODSYQCBIL-UHFFFAOYSA-N 0.000 description 1
- XDHLQPZDWFLLBX-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-(4-methoxyphenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1N1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 XDHLQPZDWFLLBX-UHFFFAOYSA-N 0.000 description 1
- RWRQJVGLXNKXAI-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-(4-methylsulfonylphenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 RWRQJVGLXNKXAI-UHFFFAOYSA-N 0.000 description 1
- DVERKLBRNMUJHI-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)=C1 DVERKLBRNMUJHI-UHFFFAOYSA-N 0.000 description 1
- BZJYUHBEBJBKFU-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridazine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 BZJYUHBEBJBKFU-UHFFFAOYSA-N 0.000 description 1
- ZXOKHOODFVNZIC-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 ZXOKHOODFVNZIC-UHFFFAOYSA-N 0.000 description 1
- CJNVQFBBNTVLGQ-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 CJNVQFBBNTVLGQ-UHFFFAOYSA-N 0.000 description 1
- KBPBPTZMSUNTBK-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 KBPBPTZMSUNTBK-UHFFFAOYSA-N 0.000 description 1
- RQSXOONFDVZBCK-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methylsulfonylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 RQSXOONFDVZBCK-UHFFFAOYSA-N 0.000 description 1
- FKPBNJOZUYPWPE-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-morpholin-4-ylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCN1CC(C=C1)=CC=C1N1CCOCC1 FKPBNJOZUYPWPE-UHFFFAOYSA-N 0.000 description 1
- KHXARCSTRQBUHC-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[[4-(methanesulfonamido)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 KHXARCSTRQBUHC-UHFFFAOYSA-N 0.000 description 1
- DSZCBNUFKPZERX-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 DSZCBNUFKPZERX-UHFFFAOYSA-N 0.000 description 1
- ODCYZWPLGOHHLR-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[4-(4-fluorophenoxy)cyclohexyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 ODCYZWPLGOHHLR-UHFFFAOYSA-N 0.000 description 1
- XSUNUTFPDUBUTM-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=C1 XSUNUTFPDUBUTM-UHFFFAOYSA-N 0.000 description 1
- WTXNEQJNAQMKMM-UHFFFAOYSA-N 6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=CC=1C(=O)NC(CC1)CCN1CC(C=C1)=CC=C1N1CCCC1 WTXNEQJNAQMKMM-UHFFFAOYSA-N 0.000 description 1
- LOCVLBUUUHGTAV-UHFFFAOYSA-N 6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)CC1 LOCVLBUUUHGTAV-UHFFFAOYSA-N 0.000 description 1
- ZZWJDICOSBHOKT-UHFFFAOYSA-N 6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=C1 ZZWJDICOSBHOKT-UHFFFAOYSA-N 0.000 description 1
- KCEAIMNCDQJEOH-UHFFFAOYSA-N 6-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)CC1 KCEAIMNCDQJEOH-UHFFFAOYSA-N 0.000 description 1
- HHOJNLQASSTSAG-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-n-methylpyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(N(C)C(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(OC)=CC=2)CC1 HHOJNLQASSTSAG-UHFFFAOYSA-N 0.000 description 1
- DRTNBWSDTRSDFI-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)CC1 DRTNBWSDTRSDFI-UHFFFAOYSA-N 0.000 description 1
- ZWIGVNWZHBPXNS-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)CC1 ZWIGVNWZHBPXNS-UHFFFAOYSA-N 0.000 description 1
- WWMWPFIHGSDSJL-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-[6-(4-methylsulfonylphenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)S(C)(=O)=O)=CC=2)CC1 WWMWPFIHGSDSJL-UHFFFAOYSA-N 0.000 description 1
- MEOATWALOAIMIC-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-methyl-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N(C)C2CCN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)CC1 MEOATWALOAIMIC-UHFFFAOYSA-N 0.000 description 1
- NVACMJIIIPZMMM-UHFFFAOYSA-N 6-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]-N-[1-[(4-methylsulfonylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound COc1ccc(OC2CCN(CC2)C(=O)c2ccc(cn2)C(=O)NC2CCN(Cc3ccc(cc3)S(C)(=O)=O)CC2)cc1 NVACMJIIIPZMMM-UHFFFAOYSA-N 0.000 description 1
- CSBDVKDQMZPDIN-UHFFFAOYSA-N 6-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)N3CCCC3)CC2)CC1 CSBDVKDQMZPDIN-UHFFFAOYSA-N 0.000 description 1
- HLFMHUFIGPKBDK-UHFFFAOYSA-N 6-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)CC1 HLFMHUFIGPKBDK-UHFFFAOYSA-N 0.000 description 1
- IRZRWLCHLOQQMF-UHFFFAOYSA-N 6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound FC(F)(F)OC1=CC=CC(CN2CCC(CC2)NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)=C1 IRZRWLCHLOQQMF-UHFFFAOYSA-N 0.000 description 1
- CYFFRIPWULCMAW-UHFFFAOYSA-N 6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 CYFFRIPWULCMAW-UHFFFAOYSA-N 0.000 description 1
- VGOONDYBJSKCBN-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-(4-fluorophenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC2)C=2C=CC(F)=CC=2)CC1 VGOONDYBJSKCBN-UHFFFAOYSA-N 0.000 description 1
- FKSSSDMQVIYXCQ-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-(4-methoxyphenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1N1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 FKSSSDMQVIYXCQ-UHFFFAOYSA-N 0.000 description 1
- BOMYFXTYBRETRO-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-(4-methylsulfonylphenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 BOMYFXTYBRETRO-UHFFFAOYSA-N 0.000 description 1
- JKAJRLZIQKBLFQ-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 JKAJRLZIQKBLFQ-UHFFFAOYSA-N 0.000 description 1
- OUYBMULCCUWUIY-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 OUYBMULCCUWUIY-UHFFFAOYSA-N 0.000 description 1
- ZEJJGUPFZSMWAX-UHFFFAOYSA-N 6-[4-[3-(cyclopropanecarbonylamino)phenoxy]piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=C(NC(=O)C3CC3)C=CC=2)CC1 ZEJJGUPFZSMWAX-UHFFFAOYSA-N 0.000 description 1
- BSKIKGJMGXCCRR-UHFFFAOYSA-N 6-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)C=C1 BSKIKGJMGXCCRR-UHFFFAOYSA-N 0.000 description 1
- VUYRMWJLJSPEAR-UHFFFAOYSA-N 6-[4-[4-(cyclopropanecarbonyl)phenoxy]piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(=O)C2CC2)CC1 VUYRMWJLJSPEAR-UHFFFAOYSA-N 0.000 description 1
- YWDIAISASAOPKH-UHFFFAOYSA-N 6-[4-[4-(cyclopropanecarbonyl)phenoxy]piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(=O)C2CC2)N=C1 YWDIAISASAOPKH-UHFFFAOYSA-N 0.000 description 1
- IRXMWPNSDLENHP-UHFFFAOYSA-N 6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(F)(F)(F)(F)F)CC1 IRXMWPNSDLENHP-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- YSAKXSLSNHUKPX-UHFFFAOYSA-N C(C1=CN=CC=C1)(=O)NC1CCN(CC1)CC1=CC=C(C=C1)N1CCCC1 Chemical compound C(C1=CN=CC=C1)(=O)NC1CCN(CC1)CC1=CC=C(C=C1)N1CCCC1 YSAKXSLSNHUKPX-UHFFFAOYSA-N 0.000 description 1
- KZZKCAHRHQVUET-UHFFFAOYSA-N C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(C)=CC=2)CC1 Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(C)=CC=2)CC1 KZZKCAHRHQVUET-UHFFFAOYSA-N 0.000 description 1
- KGDGVGWNVIEHQL-UHFFFAOYSA-N C1C(NC(=O)C2=CC=C(C(=O)N3CCC(C(=O)C4=CC=C(C)C=C4)CC3)N=C2)CCN(C1)CC1=CC=C(C#N)C=C1 Chemical compound C1C(NC(=O)C2=CC=C(C(=O)N3CCC(C(=O)C4=CC=C(C)C=C4)CC3)N=C2)CCN(C1)CC1=CC=C(C#N)C=C1 KGDGVGWNVIEHQL-UHFFFAOYSA-N 0.000 description 1
- KHKOALZGRAJSFA-UHFFFAOYSA-N CC(C)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC(C)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N KHKOALZGRAJSFA-UHFFFAOYSA-N 0.000 description 1
- ATXVRIMQWFAQOK-UHFFFAOYSA-N CC(C)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C Chemical compound CC(C)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C ATXVRIMQWFAQOK-UHFFFAOYSA-N 0.000 description 1
- JHTZDDUIDJQPJL-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N JHTZDDUIDJQPJL-UHFFFAOYSA-N 0.000 description 1
- IMOHABWBRHBSLW-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)F Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)F IMOHABWBRHBSLW-UHFFFAOYSA-N 0.000 description 1
- ULVQTPRAEGEBBG-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)F Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)F ULVQTPRAEGEBBG-UHFFFAOYSA-N 0.000 description 1
- XYCNAKIYNYYVAN-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)N6CCCC6 Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)N6CCCC6 XYCNAKIYNYYVAN-UHFFFAOYSA-N 0.000 description 1
- NDAAPEZTNBMFSX-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)OC Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)OC NDAAPEZTNBMFSX-UHFFFAOYSA-N 0.000 description 1
- NIJAFYOANGVJPO-UHFFFAOYSA-N CC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N NIJAFYOANGVJPO-UHFFFAOYSA-N 0.000 description 1
- YDHXJIHQYNMLIF-UHFFFAOYSA-N CC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C Chemical compound CC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C YDHXJIHQYNMLIF-UHFFFAOYSA-N 0.000 description 1
- PJSJDTHVWVECNP-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C PJSJDTHVWVECNP-UHFFFAOYSA-N 0.000 description 1
- LKRAGLNUAHXJNT-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC=C5)OC Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC=C5)OC LKRAGLNUAHXJNT-UHFFFAOYSA-N 0.000 description 1
- FRTBKUDRDRDNQH-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N FRTBKUDRDRDNQH-UHFFFAOYSA-N 0.000 description 1
- HFCRTCMPAUPEJW-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)CC5=CC=C(C=C5)F Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)CC5=CC=C(C=C5)F HFCRTCMPAUPEJW-UHFFFAOYSA-N 0.000 description 1
- PAIRWBQYWPIOKM-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C PAIRWBQYWPIOKM-UHFFFAOYSA-N 0.000 description 1
- WKVDROGTYQLCHC-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCC(CC4)OC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCC(CC4)OC5=CC=C(C=C5)C#N WKVDROGTYQLCHC-UHFFFAOYSA-N 0.000 description 1
- XELPDCRJZXPXEC-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC(=C5)F)F Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC(=C5)F)F XELPDCRJZXPXEC-UHFFFAOYSA-N 0.000 description 1
- SUIBOECFXUWNJD-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC=C5)OC Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC=C5)OC SUIBOECFXUWNJD-UHFFFAOYSA-N 0.000 description 1
- PQDNQTAVIFKNLY-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N PQDNQTAVIFKNLY-UHFFFAOYSA-N 0.000 description 1
- UUZOPWSYPZJFBK-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)F Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)F UUZOPWSYPZJFBK-UHFFFAOYSA-N 0.000 description 1
- GNPZRGSPKYRVQL-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)OC Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)OC GNPZRGSPKYRVQL-UHFFFAOYSA-N 0.000 description 1
- RFYYTEWAEFWDKF-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N RFYYTEWAEFWDKF-UHFFFAOYSA-N 0.000 description 1
- HHGYWGZUFUZIJY-UHFFFAOYSA-N CCC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CCC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N HHGYWGZUFUZIJY-UHFFFAOYSA-N 0.000 description 1
- OLOZIBNMGBLLJM-UHFFFAOYSA-N CNC1=C(C=CC(=C1)OC)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CNC1=C(C=CC(=C1)OC)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N OLOZIBNMGBLLJM-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical group [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 102000012437 Copper-Transporting ATPases Human genes 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000024412 Friedreich ataxia Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 206010058799 Mitochondrial encephalomyopathy Diseases 0.000 description 1
- LEUSDRGCPVXECX-FICMROCWSA-N N-[(3R)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2[C@@H](CN(CC=3C=CC(=CC=3)C#N)CC2)F)CC1 LEUSDRGCPVXECX-FICMROCWSA-N 0.000 description 1
- CKXPBSUKGATDRJ-SANMLTNESA-N N-[(3S)-1-[(4-cyanophenyl)methyl]pyrrolidin-3-yl]-5-[4-[(4-fluorophenyl)methyl]-3-oxopiperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound Fc1ccc(CN2CCN(CC2=O)C(=O)c2ccc(nc2)C(=O)N[C@H]2CCN(Cc3ccc(cc3)C#N)C2)cc1 CKXPBSUKGATDRJ-SANMLTNESA-N 0.000 description 1
- LEUSDRGCPVXECX-URLMMPGGSA-N N-[(3S,4R)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@H](CN(CC=3C=CC(=CC=3)C#N)CC2)F)CC1 LEUSDRGCPVXECX-URLMMPGGSA-N 0.000 description 1
- HWOSDYNCBXZMQP-WUFINQPMSA-N N-[(3S,4R)-3-fluoro-1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@H](CN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)F)CC1 HWOSDYNCBXZMQP-WUFINQPMSA-N 0.000 description 1
- CGHXVKSEPXSOKT-UHFFFAOYSA-N N-[1-(4-cyanophenoxy)piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound COc1ccc(cc1)C(=O)C1CCN(CC1)C(=O)c1ccc(cn1)C(=O)NC1CCN(CC1)Oc1ccc(cc1)C#N CGHXVKSEPXSOKT-UHFFFAOYSA-N 0.000 description 1
- PBWMNTCCVDFBFE-UHFFFAOYSA-N N-[1-(4-fluorophenoxy)piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound COc1ccc(cc1)C(=O)C1CCN(CC1)C(=O)c1ccc(cn1)C(=O)NC1CCN(CC1)Oc1ccc(F)cc1 PBWMNTCCVDFBFE-UHFFFAOYSA-N 0.000 description 1
- AJYLLLGCOILHRH-UHFFFAOYSA-N N-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(dimethylamino)benzoyl]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound CN(C)c1ccc(cc1)C(=O)C1CCN(CC1)C(=O)c1ccc(cn1)C(=O)NC1CCN(Cc2ccc(cc2)C#N)CC1 AJYLLLGCOILHRH-UHFFFAOYSA-N 0.000 description 1
- ILMFTSMWOSIQRL-UHFFFAOYSA-N N-[4-(4-cyano-3-fluorophenoxy)cyclohexyl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound COc1ccc(OC2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCC(CC2)Oc2ccc(C#N)c(F)c2)cc1 ILMFTSMWOSIQRL-UHFFFAOYSA-N 0.000 description 1
- FWSGCPSSGXJESZ-UHFFFAOYSA-N N-[4-(4-cyano-3-fluorophenoxy)cyclohexyl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(C#N)C(F)=CC(OC2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)=C1 FWSGCPSSGXJESZ-UHFFFAOYSA-N 0.000 description 1
- DXFJCXIKMLXEJV-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 DXFJCXIKMLXEJV-UHFFFAOYSA-N 0.000 description 1
- GIQKDCHBWREEQP-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 GIQKDCHBWREEQP-UHFFFAOYSA-N 0.000 description 1
- QMWAQWPUELAOOP-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 QMWAQWPUELAOOP-UHFFFAOYSA-N 0.000 description 1
- KNSGWXFUNINQIP-UHFFFAOYSA-N N-[4-(4-methoxyphenoxy)cyclohexyl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(OC)=CC=2)CC1 KNSGWXFUNINQIP-UHFFFAOYSA-N 0.000 description 1
- QKTLBWHRMYOPPU-UHFFFAOYSA-N N-[4-(4-methoxyphenoxy)cyclohexyl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 QKTLBWHRMYOPPU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 208000018839 Wilson disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- CHWFYLUDMGYJQK-UHFFFAOYSA-N [1-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 CHWFYLUDMGYJQK-UHFFFAOYSA-N 0.000 description 1
- SZJATISBSPFCJL-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(3-phenylanilino)pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC=3C=C(C=CC=3)C=3C=CC=CC=3)=CC=2)CC1 SZJATISBSPFCJL-UHFFFAOYSA-N 0.000 description 1
- QSFRHVLXMAFXQR-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(3-phenylmethoxyphenyl)pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C=2C=C(OCC=3C=CC=CC=3)C=CC=2)CC1 QSFRHVLXMAFXQR-UHFFFAOYSA-N 0.000 description 1
- SCZKOAZZRCYNFT-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(4-phenoxyanilino)pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC=3C=CC(OC=4C=CC=CC=4)=CC=3)=CC=2)CC1 SCZKOAZZRCYNFT-UHFFFAOYSA-N 0.000 description 1
- LFRKRHVIDSBBJO-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(4-phenylmethoxyphenyl)pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C=2C=CC(OCC=3C=CC=CC=3)=CC=2)CC1 LFRKRHVIDSBBJO-UHFFFAOYSA-N 0.000 description 1
- HOVNBOLMJBLKSZ-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(4-phenylpiperazine-1-carbonyl)pyridin-2-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=C(C=CC=2)C(=O)N2CCN(CC2)C=2C=CC=CC=2)CC1 HOVNBOLMJBLKSZ-UHFFFAOYSA-N 0.000 description 1
- UKCFFODPBLWFIW-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-[4-(2-phenylethyl)piperazine-1-carbonyl]pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)CC1 UKCFFODPBLWFIW-UHFFFAOYSA-N 0.000 description 1
- NLRIVKKELMUADS-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-[4-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 NLRIVKKELMUADS-UHFFFAOYSA-N 0.000 description 1
- VPTJAMUGKWOOJY-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-[[1-[(4-fluorophenyl)methyl]pyrazol-4-yl]amino]pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC3=CN(CC=4C=CC(F)=CC=4)N=C3)=CC=2)CC1 VPTJAMUGKWOOJY-UHFFFAOYSA-N 0.000 description 1
- PXCXFGLKFBBGMD-UHFFFAOYSA-N [6-(4-benzylanilino)pyridin-3-yl]-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC=3C=CC(CC=4C=CC=CC=4)=CC=3)=CC=2)CC1 PXCXFGLKFBBGMD-UHFFFAOYSA-N 0.000 description 1
- HLMPLICAEPSBJM-UHFFFAOYSA-N [6-(4-benzylpiperazine-1-carbonyl)pyridin-3-yl]-(4-benzylpiperazin-1-yl)methanone Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CC=CC=3)CC2)N=CC=1C(=O)N(CC1)CCN1CC1=CC=CC=C1 HLMPLICAEPSBJM-UHFFFAOYSA-N 0.000 description 1
- DILDXNXKQQSZDE-UHFFFAOYSA-N [6-[4-(2-phenylethyl)piperazine-1-carbonyl]pyridin-3-yl]-(4-phenylpiperazin-1-yl)methanone Chemical compound C=1C=C(C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)N=CC=1C(=O)N(CC1)CCN1C1=CC=CC=C1 DILDXNXKQQSZDE-UHFFFAOYSA-N 0.000 description 1
- WELVWANXLGVWPI-UHFFFAOYSA-N [6-[4-(2-phenylethyl)piperazine-1-carbonyl]pyridin-3-yl]-(4-propan-2-ylpiperazin-1-yl)methanone Chemical compound C1CN(C(C)C)CCN1C(=O)C1=CC=C(C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)N=C1 WELVWANXLGVWPI-UHFFFAOYSA-N 0.000 description 1
- XIBAGROKRXXCJI-UHFFFAOYSA-N [6-[4-(2-phenylethyl)piperazine-1-carbonyl]pyridin-3-yl]-[4-(2-phenylethyl)piperazin-1-yl]methanone Chemical compound C=1C=C(C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)N=CC=1C(=O)N(CC1)CCN1CCC1=CC=CC=C1 XIBAGROKRXXCJI-UHFFFAOYSA-N 0.000 description 1
- KXOMWEWZJKBODO-UHFFFAOYSA-N [6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]-[4-(2-phenylethyl)piperazin-1-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=C(C=CC=2)C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)CC1 KXOMWEWZJKBODO-UHFFFAOYSA-N 0.000 description 1
- ZCVDBEVZVHBBJC-UHFFFAOYSA-N [6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-3-yl]-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 ZCVDBEVZVHBBJC-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- QBCOHMKIOZPEPA-UHFFFAOYSA-N ethyl 4-[1-[6-[[1-[(4-cyanophenyl)methyl]piperidin-4-yl]carbamoyl]pyridine-3-carbonyl]piperidin-4-yl]oxybenzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 QBCOHMKIOZPEPA-UHFFFAOYSA-N 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- PGYYJEYPHRIKEA-UHFFFAOYSA-N n-(1-benzoylpiperidin-4-yl)-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)C(=O)C=2C=CC=CC=2)CC1 PGYYJEYPHRIKEA-UHFFFAOYSA-N 0.000 description 1
- SIUGKYLYXCIBJK-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(3-phenoxyanilino)pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=C(OC=3C=CC=CC=3)C=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 SIUGKYLYXCIBJK-UHFFFAOYSA-N 0.000 description 1
- ALWPRGJHZOZRBU-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(3-phenylanilino)pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=C(C=CC=2)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 ALWPRGJHZOZRBU-UHFFFAOYSA-N 0.000 description 1
- DBXTZCORMIZYNR-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(4-phenoxyanilino)pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=CC(OC=3C=CC=CC=3)=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 DBXTZCORMIZYNR-UHFFFAOYSA-N 0.000 description 1
- UHYHAUUNDGYPEZ-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(4-phenylpiperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 UHYHAUUNDGYPEZ-UHFFFAOYSA-N 0.000 description 1
- LZSZSQKOWNJKPK-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(4-pyridin-4-ylpiperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C=2C=CN=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 LZSZSQKOWNJKPK-UHFFFAOYSA-N 0.000 description 1
- GWJLUAVBJOJUAI-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-[4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound O1C(C)=CC(CN2CCN(CC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC=CC=3)CC2)=N1 GWJLUAVBJOJUAI-UHFFFAOYSA-N 0.000 description 1
- IVEYKDVYNMMLFY-UHFFFAOYSA-N n-(4-benzoylphenyl)-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)CC1 IVEYKDVYNMMLFY-UHFFFAOYSA-N 0.000 description 1
- VRFSYYBIXZHSAS-UHFFFAOYSA-N n-(4-benzylphenyl)-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(CC=3C=CC=CC=3)=CC=2)CC1 VRFSYYBIXZHSAS-UHFFFAOYSA-N 0.000 description 1
- MTYUQDCNXVHHAR-UHFFFAOYSA-N n-(4-bromophenyl)-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(Br)=CC=2)CC1 MTYUQDCNXVHHAR-UHFFFAOYSA-N 0.000 description 1
- ZTMNZDLYLCMZAQ-HHHXNRCGSA-N n-[(3r)-1-[(4-cyanophenyl)methyl]pyrrolidin-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N[C@H]2CN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ZTMNZDLYLCMZAQ-HHHXNRCGSA-N 0.000 description 1
- LEUSDRGCPVXECX-FQLXRVMXSA-N n-[(3r,4r)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(=CC=3)C#N)CC2)F)CC1 LEUSDRGCPVXECX-FQLXRVMXSA-N 0.000 description 1
- MPRAAOIVYGMJKJ-FIRIVFDPSA-N n-[(3r,4r)-3-fluoro-1-[(4-propan-2-yloxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(OC(C)C)=CC=3)CC2)F)CC1 MPRAAOIVYGMJKJ-FIRIVFDPSA-N 0.000 description 1
- HWOSDYNCBXZMQP-VSGBNLITSA-N n-[(3r,4r)-3-fluoro-1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)F)CC1 HWOSDYNCBXZMQP-VSGBNLITSA-N 0.000 description 1
- GGMOGBNZFSCMDK-WUFINQPMSA-N n-[(3s,4r)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)F)N1CC1=CC=C(C#N)C=C1 GGMOGBNZFSCMDK-WUFINQPMSA-N 0.000 description 1
- IGRUICVFLYEORO-UHFFFAOYSA-N n-[(4-cyanophenyl)methyl]-3-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]benzamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C=2C=C(C=CC=2)C(=O)NCC=2C=CC(=CC=2)C#N)CC1 IGRUICVFLYEORO-UHFFFAOYSA-N 0.000 description 1
- PTFCCBDWBUWRTB-UHFFFAOYSA-N n-[(4-cyanophenyl)methyl]-4-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]benzamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C=2C=CC(=CC=2)C(=O)NCC=2C=CC(=CC=2)C#N)CC1 PTFCCBDWBUWRTB-UHFFFAOYSA-N 0.000 description 1
- LTAMCBAUTUHECW-UHFFFAOYSA-N n-[(4-cyanophenyl)methyl]-4-[[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]amino]benzamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC=3C=CC(=CC=3)C(=O)NCC=3C=CC(=CC=3)C#N)=CC=2)CC1 LTAMCBAUTUHECW-UHFFFAOYSA-N 0.000 description 1
- AIJFSOPJUPPZAC-UHFFFAOYSA-N n-[1-(4-cyanobenzoyl)piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)C(=O)C=2C=CC(=CC=2)C#N)CC1 AIJFSOPJUPPZAC-UHFFFAOYSA-N 0.000 description 1
- MHLHQNWCMLCICH-UHFFFAOYSA-N n-[1-(4-cyanophenyl)piperidin-4-yl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC2)C=2C=CC(=CC=2)C#N)CC1 MHLHQNWCMLCICH-UHFFFAOYSA-N 0.000 description 1
- MJVVGQPISJDCKE-UHFFFAOYSA-N n-[1-(4-cyanophenyl)sulfonylpiperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)S(=O)(=O)C=2C=CC(=CC=2)C#N)CC1 MJVVGQPISJDCKE-UHFFFAOYSA-N 0.000 description 1
- KUYAVZMMGBODBA-UHFFFAOYSA-N n-[1-(cyclohexanecarbonyl)piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)C(=O)C2CCCCC2)CC1 KUYAVZMMGBODBA-UHFFFAOYSA-N 0.000 description 1
- KCGHFTHUSALUFF-UHFFFAOYSA-N n-[1-(cyclohexylmethyl)piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC3CCCCC3)CC2)CC1 KCGHFTHUSALUFF-UHFFFAOYSA-N 0.000 description 1
- ADMHSPDKZAALOS-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 ADMHSPDKZAALOS-UHFFFAOYSA-N 0.000 description 1
- JTXPMIJNGKYFRZ-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[3-[(4-fluorophenyl)methoxy]azetidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1COC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)C1 JTXPMIJNGKYFRZ-UHFFFAOYSA-N 0.000 description 1
- QPCNUSNHBFCPAM-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 QPCNUSNHBFCPAM-UHFFFAOYSA-N 0.000 description 1
- PQSYSUQLVSDROG-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 PQSYSUQLVSDROG-UHFFFAOYSA-N 0.000 description 1
- HIVGHAUHDXNYQB-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 HIVGHAUHDXNYQB-UHFFFAOYSA-N 0.000 description 1
- ZKEBDQJMFGPWQM-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 ZKEBDQJMFGPWQM-UHFFFAOYSA-N 0.000 description 1
- JEBWTTQATIZHGU-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 JEBWTTQATIZHGU-UHFFFAOYSA-N 0.000 description 1
- APBUQRJICSRSSS-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)=C1 APBUQRJICSRSSS-UHFFFAOYSA-N 0.000 description 1
- HFGMPLDTNKSDKF-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 HFGMPLDTNKSDKF-UHFFFAOYSA-N 0.000 description 1
- HVGXPVKSQJFBCU-UHFFFAOYSA-N n-[1-[(4-acetamidophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(NC(C)=O)=CC=3)CC2)CC1 HVGXPVKSQJFBCU-UHFFFAOYSA-N 0.000 description 1
- RIUDPAORZJBEQE-UHFFFAOYSA-N n-[1-[(4-aminophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(N)=CC=3)CC2)CC1 RIUDPAORZJBEQE-UHFFFAOYSA-N 0.000 description 1
- KAGDFRKVOFDGOY-UHFFFAOYSA-N n-[1-[(4-carbamoylphenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)N)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 KAGDFRKVOFDGOY-UHFFFAOYSA-N 0.000 description 1
- LQGICZMHJVYZGC-UHFFFAOYSA-N n-[1-[(4-cyano-3-fluorophenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=C(C#N)C(F)=CC(CN2CCC(CC2)NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)=C1 LQGICZMHJVYZGC-UHFFFAOYSA-N 0.000 description 1
- GLKJXMSLKUEYGJ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]-3,3-difluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2C(CN(CC=3C=CC(=CC=3)C#N)CC2)(F)F)CC1 GLKJXMSLKUEYGJ-UHFFFAOYSA-N 0.000 description 1
- XECSTZQZWRCGSO-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-(4-phenylanilino)pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=CC(=CC=2)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 XECSTZQZWRCGSO-UHFFFAOYSA-N 0.000 description 1
- SXPSAQUONWUCPN-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-(4-propan-2-ylpiperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C1CN(C(C)C)CCN1C(=O)C1=CC=C(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)N=C1 SXPSAQUONWUCPN-UHFFFAOYSA-N 0.000 description 1
- AHTSNSKNLLGNAL-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-(4-pyridin-4-yloxypiperidine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CN=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 AHTSNSKNLLGNAL-UHFFFAOYSA-N 0.000 description 1
- XJFFGYUNDZFZOG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-(piperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCNCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 XJFFGYUNDZFZOG-UHFFFAOYSA-N 0.000 description 1
- CQIGWVFBNAADFU-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[(1-phenylpiperidin-4-yl)amino]pyridine-2-carboxamide Chemical compound C=1C=C(NC2CCN(CC2)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 CQIGWVFBNAADFU-UHFFFAOYSA-N 0.000 description 1
- RLJZRJSNAZYVPY-HHHXNRCGSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[(3r)-3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1O[C@H]1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RLJZRJSNAZYVPY-HHHXNRCGSA-N 0.000 description 1
- KABCVIPOCMQHMB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[2-[(4-fluorophenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CC1N(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CCCC1 KABCVIPOCMQHMB-UHFFFAOYSA-N 0.000 description 1
- RSHRVHMHGAFLSZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-(3-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound COC1=CC=CC(OC2CN(CCC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=C1 RSHRVHMHGAFLSZ-UHFFFAOYSA-N 0.000 description 1
- RLJZRJSNAZYVPY-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RLJZRJSNAZYVPY-UHFFFAOYSA-N 0.000 description 1
- KFXYGIMFSTTWQR-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CCC1 KFXYGIMFSTTWQR-UHFFFAOYSA-N 0.000 description 1
- JUPFXDZHGLSJJR-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-[(4-fluorophenyl)methoxy]azetidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1COC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)C1 JUPFXDZHGLSJJR-UHFFFAOYSA-N 0.000 description 1
- SWDLJAZQRMNAGX-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-[(4-fluorophenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CCC1 SWDLJAZQRMNAGX-UHFFFAOYSA-N 0.000 description 1
- BYANCVXDXHRQLT-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(2,2-dimethylpropanoyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1CN(C(=O)C(C)(C)C)CCN1C(=O)C1=CC=C(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)N=C1 BYANCVXDXHRQLT-UHFFFAOYSA-N 0.000 description 1
- XRDMDDSSWUSOAX-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 XRDMDDSSWUSOAX-UHFFFAOYSA-N 0.000 description 1
- NTZCHZCFSJZAQG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(2,4-difluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 NTZCHZCFSJZAQG-UHFFFAOYSA-N 0.000 description 1
- ANTKASWXMLJFBB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(2-phenylpropan-2-yl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=CC=CC=1C(C)(C)N(CC1)CCN1C(=O)C(C=N1)=CC=C1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 ANTKASWXMLJFBB-UHFFFAOYSA-N 0.000 description 1
- RVVFUTBGTJOJLC-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(3,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(F)C(F)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RVVFUTBGTJOJLC-UHFFFAOYSA-N 0.000 description 1
- BUTSOOYTBYLGPV-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(3,4-difluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(F)C(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 BUTSOOYTBYLGPV-UHFFFAOYSA-N 0.000 description 1
- CWUZNYCHXNYQDR-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-cyclopropylsulfonylphenyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C=2C=CC(=CC=2)S(=O)(=O)C2CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 CWUZNYCHXNYQDR-UHFFFAOYSA-N 0.000 description 1
- RXZOTKZCZZFCCH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorobenzoyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1C(=O)N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RXZOTKZCZZFCCH-UHFFFAOYSA-N 0.000 description 1
- QZCUYXGDXFPQEA-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 QZCUYXGDXFPQEA-UHFFFAOYSA-N 0.000 description 1
- KAPJCNOKYHCMQW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorophenyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 KAPJCNOKYHCMQW-UHFFFAOYSA-N 0.000 description 1
- MDZHPVWRGQFKCQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorophenyl)sulfonylpiperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 MDZHPVWRGQFKCQ-UHFFFAOYSA-N 0.000 description 1
- WPGURWCGKIGDPP-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 WPGURWCGKIGDPP-UHFFFAOYSA-N 0.000 description 1
- LXDHLOOAVAFEJF-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 LXDHLOOAVAFEJF-UHFFFAOYSA-N 0.000 description 1
- HVAFECNXPDQFSX-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidin-1-yl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 HVAFECNXPDQFSX-UHFFFAOYSA-N 0.000 description 1
- NPKHHIRWHYYJGW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=NC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 NPKHHIRWHYYJGW-UHFFFAOYSA-N 0.000 description 1
- POEZYVXOVVWICH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 POEZYVXOVVWICH-UHFFFAOYSA-N 0.000 description 1
- AVWVDLCYEHDFRA-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxyphenyl)sulfonylpiperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 AVWVDLCYEHDFRA-UHFFFAOYSA-N 0.000 description 1
- HQFKPRNNDOUANQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC1CCN(C(=O)C=2N=CC(=NC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 HQFKPRNNDOUANQ-UHFFFAOYSA-N 0.000 description 1
- FCLDRVKLOOYCDQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylsulfanylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(SC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 FCLDRVKLOOYCDQ-UHFFFAOYSA-N 0.000 description 1
- WCBBIBOXLBNHOV-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-morpholin-4-ylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCOCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WCBBIBOXLBNHOV-UHFFFAOYSA-N 0.000 description 1
- HVWHBZWYBCRQOP-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C=1N=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 HVWHBZWYBCRQOP-UHFFFAOYSA-N 0.000 description 1
- UXNBFMGMBOACEC-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 UXNBFMGMBOACEC-UHFFFAOYSA-N 0.000 description 1
- WFWVYMHDWSBWSD-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(cyclohexanecarbonyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C(=O)C2CCCCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WFWVYMHDWSBWSD-UHFFFAOYSA-N 0.000 description 1
- YJICAVIHOWJTJS-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(cyclohexylmethyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC3CCCCC3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 YJICAVIHOWJTJS-UHFFFAOYSA-N 0.000 description 1
- NMCSHUMJBBZUEI-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(oxan-4-yl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C2CCOCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 NMCSHUMJBBZUEI-UHFFFAOYSA-N 0.000 description 1
- RMUCYZDCFKRSNY-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(pyridin-4-ylmethyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CN=CC=3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 RMUCYZDCFKRSNY-UHFFFAOYSA-N 0.000 description 1
- PXNMSZNSQODFJQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(3,5-difluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCN(CC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=C1 PXNMSZNSQODFJQ-UHFFFAOYSA-N 0.000 description 1
- XGUKVBQSHUARJJ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(3-fluoro-4-methoxyphenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(F)C(OC)=CC=C1CC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 XGUKVBQSHUARJJ-UHFFFAOYSA-N 0.000 description 1
- SBPPXQVCQDZTHN-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(3-methoxyphenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound COC1=CC=CC(CC2CCN(CC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=C1 SBPPXQVCQDZTHN-UHFFFAOYSA-N 0.000 description 1
- WNLKAYDTKKISBN-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)-hydroxymethyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(F)C=CC=1C(O)C(CC1)CCN1C(=O)C(C=N1)=CC=C1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WNLKAYDTKKISBN-UHFFFAOYSA-N 0.000 description 1
- CCVJKVSSPUWIOG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]-3,3-dimethylpiperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound CC1(C)CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CCN1CC1=CC=C(F)C=C1 CCVJKVSSPUWIOG-UHFFFAOYSA-N 0.000 description 1
- NDMQOBJALHHUBI-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 NDMQOBJALHHUBI-UHFFFAOYSA-N 0.000 description 1
- WPSUUXHDAQDYPG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-methoxyphenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 WPSUUXHDAQDYPG-UHFFFAOYSA-N 0.000 description 1
- CXYVYGXMFQSTKH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-methoxyphenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CXYVYGXMFQSTKH-UHFFFAOYSA-N 0.000 description 1
- GAXYQFRRJQSHAN-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-methylphenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1CC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 GAXYQFRRJQSHAN-UHFFFAOYSA-N 0.000 description 1
- RGJWOFQNRMIXJW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(2,2,2-trifluoroacetyl)phenyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)C(F)(F)F)=CC=C1N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RGJWOFQNRMIXJW-UHFFFAOYSA-N 0.000 description 1
- YFJQTHWORCUTFF-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2N=CC(=NC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)C=C1 YFJQTHWORCUTFF-UHFFFAOYSA-N 0.000 description 1
- CQUHOAICBBXVEG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)C=C1 CQUHOAICBBXVEG-UHFFFAOYSA-N 0.000 description 1
- SRJYEJPJELERDT-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(cyclopropanecarbonyl)phenyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C=2C=CC(=CC=2)C(=O)C2CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 SRJYEJPJELERDT-UHFFFAOYSA-N 0.000 description 1
- HUYCPHYFJJCRHE-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(dimethylcarbamoyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 HUYCPHYFJJCRHE-UHFFFAOYSA-N 0.000 description 1
- BAQNKGBJRYOBKF-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(F)(F)(F)(F)F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 BAQNKGBJRYOBKF-UHFFFAOYSA-N 0.000 description 1
- JHRNQZYMFIIVGE-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 JHRNQZYMFIIVGE-UHFFFAOYSA-N 0.000 description 1
- AFFMBBJVFRZUEW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=CC(=NC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 AFFMBBJVFRZUEW-UHFFFAOYSA-N 0.000 description 1
- SWFYJWRPKQUXJE-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 SWFYJWRPKQUXJE-UHFFFAOYSA-N 0.000 description 1
- ZRFMAUMUQYAFKO-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ZRFMAUMUQYAFKO-UHFFFAOYSA-N 0.000 description 1
- CUGRGOQWDRJFLR-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethylsulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(SC(F)(F)F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CUGRGOQWDRJFLR-UHFFFAOYSA-N 0.000 description 1
- CIYOQUUILYLVDA-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethylsulfonyl)phenyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C(F)(F)F)=CC=C1N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CIYOQUUILYLVDA-UHFFFAOYSA-N 0.000 description 1
- FJNHSBVZTQFKEF-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[fluoro-(4-fluorophenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(F)C=CC=1C(F)C(CC1)CCN1C(=O)C(C=N1)=CC=C1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 FJNHSBVZTQFKEF-UHFFFAOYSA-N 0.000 description 1
- WQUGCKCCOOBUNT-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-fluoro-4-(4-fluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1C(=O)C1(F)CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 WQUGCKCCOOBUNT-UHFFFAOYSA-N 0.000 description 1
- SXLNCLDXSZOPBZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[[1-(4-cyanophenyl)piperidin-4-yl]amino]pyridine-2-carboxamide Chemical compound C=1C=C(NC2CCN(CC2)C=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 SXLNCLDXSZOPBZ-UHFFFAOYSA-N 0.000 description 1
- WDIUOLAJMWXWDH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[[1-(4-fluorophenyl)piperidin-4-yl]amino]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1N1CCC(NC=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 WDIUOLAJMWXWDH-UHFFFAOYSA-N 0.000 description 1
- KXVNZBABMIWAFP-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[[1-(4-methoxyphenyl)piperidin-4-yl]amino]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1N1CCC(NC=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 KXVNZBABMIWAFP-UHFFFAOYSA-N 0.000 description 1
- CZGHJHFJDOKLEU-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CZGHJHFJDOKLEU-UHFFFAOYSA-N 0.000 description 1
- CQZOSLVFDRPCFJ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(2,4-difluorophenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CQZOSLVFDRPCFJ-UHFFFAOYSA-N 0.000 description 1
- CINVMDLCMBUCQO-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 CINVMDLCMBUCQO-UHFFFAOYSA-N 0.000 description 1
- JZZXYUGABUNNTJ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 JZZXYUGABUNNTJ-UHFFFAOYSA-N 0.000 description 1
- PNQUXRANYGABJB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxy-2-nitrophenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 PNQUXRANYGABJB-UHFFFAOYSA-N 0.000 description 1
- UZPPXFTWQGIEIS-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidin-1-yl]pyridazine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 UZPPXFTWQGIEIS-UHFFFAOYSA-N 0.000 description 1
- FRYJAPPODQHJRU-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-methylpyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N(C)C2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 FRYJAPPODQHJRU-UHFFFAOYSA-N 0.000 description 1
- ZLENIQODLNSTCZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridazine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ZLENIQODLNSTCZ-UHFFFAOYSA-N 0.000 description 1
- JKGJLUCJLNJXKG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 JKGJLUCJLNJXKG-UHFFFAOYSA-N 0.000 description 1
- DSEUJSHMFHEHFZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-nitrophenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 DSEUJSHMFHEHFZ-UHFFFAOYSA-N 0.000 description 1
- JHDUODWCMKEUJW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 JHDUODWCMKEUJW-UHFFFAOYSA-N 0.000 description 1
- PDHJZIQJMYUJNZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]pyridazine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 PDHJZIQJMYUJNZ-UHFFFAOYSA-N 0.000 description 1
- USKHWBFFPMZFMQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[2-(dimethylamino)-4-methoxyphenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound CN(C)C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 USKHWBFFPMZFMQ-UHFFFAOYSA-N 0.000 description 1
- DNOOJFBSTXDBIH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)C=C1 DNOOJFBSTXDBIH-UHFFFAOYSA-N 0.000 description 1
- MPYZAJHIMPJCAB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(cyclopropanecarbonylamino)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1CC1C(=O)NC(C=C1)=CC=C1OC(CC1)CCN1C(=O)C(N=C1)=CC=C1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 MPYZAJHIMPJCAB-UHFFFAOYSA-N 0.000 description 1
- CLJBRWCXTFMREC-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(cyclopropylsulfonylamino)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(NS(=O)(=O)C3CC3)=CC=2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 CLJBRWCXTFMREC-UHFFFAOYSA-N 0.000 description 1
- GJMRQEGEEYASHD-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(methanesulfonamido)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 GJMRQEGEEYASHD-UHFFFAOYSA-N 0.000 description 1
- YQNDTFLKFFIKOY-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(S(F)(F)(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 YQNDTFLKFFIKOY-UHFFFAOYSA-N 0.000 description 1
- YTSTYPROPVLXLB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridazine-3-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 YTSTYPROPVLXLB-UHFFFAOYSA-N 0.000 description 1
- PKZHINNMONLOBK-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(trifluoromethylsulfanyl)phenoxy]piperidine-1-carbonyl]pyridazine-3-carboxamide Chemical compound C1=CC(SC(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 PKZHINNMONLOBK-UHFFFAOYSA-N 0.000 description 1
- XVUVHIMZDREIIH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(trifluoromethylsulfonyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 XVUVHIMZDREIIH-UHFFFAOYSA-N 0.000 description 1
- JPHNAIFCKPLXEH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=CC=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 JPHNAIFCKPLXEH-UHFFFAOYSA-N 0.000 description 1
- RJDFHCCYYFFSBE-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]pyrazol-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2=NN(CC=3C=CC(=CC=3)C#N)C=C2)CC1 RJDFHCCYYFFSBE-UHFFFAOYSA-N 0.000 description 1
- NFOUIFJMANKDPS-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]pyrazol-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2=CN(CC=3C=CC(=CC=3)C#N)N=C2)CC1 NFOUIFJMANKDPS-UHFFFAOYSA-N 0.000 description 1
- MYKBCPMYGPOKII-UHFFFAOYSA-N n-[1-[(4-fluoro-3-methylphenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(F)C(C)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)=C1 MYKBCPMYGPOKII-UHFFFAOYSA-N 0.000 description 1
- HMMQLGQVAFWIOP-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 HMMQLGQVAFWIOP-UHFFFAOYSA-N 0.000 description 1
- WETBWPNUDSHYAH-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 WETBWPNUDSHYAH-UHFFFAOYSA-N 0.000 description 1
- LNDMBSSQDKPZBK-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 LNDMBSSQDKPZBK-UHFFFAOYSA-N 0.000 description 1
- UWFMRHLPQYNROO-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 UWFMRHLPQYNROO-UHFFFAOYSA-N 0.000 description 1
- RVROKBCZVIZYLZ-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 RVROKBCZVIZYLZ-UHFFFAOYSA-N 0.000 description 1
- KNIWBJVPMSYDST-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 KNIWBJVPMSYDST-UHFFFAOYSA-N 0.000 description 1
- INGGFDWTZNSBPY-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 INGGFDWTZNSBPY-UHFFFAOYSA-N 0.000 description 1
- RMZUHPQXWRXPOP-UHFFFAOYSA-N n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(C)=CC=2)CC1 RMZUHPQXWRXPOP-UHFFFAOYSA-N 0.000 description 1
- LLRSNVNZYTWKPN-UHFFFAOYSA-N n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 LLRSNVNZYTWKPN-UHFFFAOYSA-N 0.000 description 1
- MZWKXTIWRUKNLP-UHFFFAOYSA-N n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(F)(F)(F)(F)F)CC1 MZWKXTIWRUKNLP-UHFFFAOYSA-N 0.000 description 1
- HUMCBAOVNNNRNA-UHFFFAOYSA-N n-[1-[(4-propan-2-yloxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC(C)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 HUMCBAOVNNNRNA-UHFFFAOYSA-N 0.000 description 1
- PJUPLDXIIBQNBZ-UHFFFAOYSA-N n-[1-[2-(4-cyanophenyl)propan-2-yl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C#N)C=CC=1C(C)(C)N(CC1)CCC1NC(=O)C(N=C1)=CC=C1C(=O)N(CC1)CCN1CC1=CC=C(F)C=C1 PJUPLDXIIBQNBZ-UHFFFAOYSA-N 0.000 description 1
- MJFMCJRNWDTCIF-UHFFFAOYSA-N n-[1-[[4-(dimethylcarbamoyl)phenyl]methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C(=O)N(C)C)CC2)CC1 MJFMCJRNWDTCIF-UHFFFAOYSA-N 0.000 description 1
- HVUHUGNDUZGZJI-NVVQJRFUSA-N n-[1-[[4-[3-[2-[2-[2-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethoxy]ethoxy]ethoxy]propanoylamino]phenyl]methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(NC(=O)CCOCCOCCOCCNC(=O)CCCC[C@H]4[C@H]5NC(=O)N[C@H]5CS4)=CC=3)CC2)CC1 HVUHUGNDUZGZJI-NVVQJRFUSA-N 0.000 description 1
- MLGAAABCCVIOEF-UHFFFAOYSA-N n-[2-(4-fluorophenoxy)ethyl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NCCOC=2C=CC(F)=CC=2)CC1 MLGAAABCCVIOEF-UHFFFAOYSA-N 0.000 description 1
- BIPLDIXMEWFTMU-UHFFFAOYSA-N n-[2-[(4-cyanophenyl)methyl]-3,4-dihydro-1h-isoquinolin-7-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=C3CN(CC=4C=CC(=CC=4)C#N)CCC3=CC=2)CC1 BIPLDIXMEWFTMU-UHFFFAOYSA-N 0.000 description 1
- WBQCMGADTQIKRW-UHFFFAOYSA-N n-[4-(3,5-difluorophenoxy)cyclohexyl]-5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=C(F)C=C(F)C=2)CC1 WBQCMGADTQIKRW-UHFFFAOYSA-N 0.000 description 1
- WUUYOPINRPLTPV-UHFFFAOYSA-N n-[4-(3,5-difluorophenoxy)cyclohexyl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=C(F)C=C(F)C=2)CC1 WUUYOPINRPLTPV-UHFFFAOYSA-N 0.000 description 1
- ZGVPWOWZROQALT-UHFFFAOYSA-N n-[4-(3-cyanophenoxy)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=C(C=CC=3)C#N)=CC=2)CC1 ZGVPWOWZROQALT-UHFFFAOYSA-N 0.000 description 1
- GVARIDOMGKXGSD-UHFFFAOYSA-N n-[4-(3-cyanophenyl)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C=2C=C(C=CC=2)C#N)CC1 GVARIDOMGKXGSD-UHFFFAOYSA-N 0.000 description 1
- AFHGWQBLKGCROK-UHFFFAOYSA-N n-[4-(3-fluorophenoxy)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=C(F)C=CC=3)=CC=2)CC1 AFHGWQBLKGCROK-UHFFFAOYSA-N 0.000 description 1
- RRLULESDYPQECY-YTZIBCIGSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-5-[(3s)-3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1O[C@@H]1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 RRLULESDYPQECY-YTZIBCIGSA-N 0.000 description 1
- QXYDKUCICQMFKB-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCC1OC1=CC=C(C#N)C=C1 QXYDKUCICQMFKB-UHFFFAOYSA-N 0.000 description 1
- PWNFGRQMNJTNJN-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)N=CC=1C(=O)NC(CC1)CCC1OC1=CC=C(C#N)C=C1 PWNFGRQMNJTNJN-UHFFFAOYSA-N 0.000 description 1
- QMTWAPVKHUNKFZ-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 QMTWAPVKHUNKFZ-UHFFFAOYSA-N 0.000 description 1
- JKWVHOJBLXODFV-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-6-[4-[3-(cyclopropanecarbonylamino)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1CC1C(=O)NC(C=1)=CC=CC=1OC(CC1)CCN1C(=O)C(N=C1)=CC=C1C(=O)NC(CC1)CCC1OC1=CC=C(C#N)C=C1 JKWVHOJBLXODFV-UHFFFAOYSA-N 0.000 description 1
- RANWOMLEXKWTRY-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 RANWOMLEXKWTRY-UHFFFAOYSA-N 0.000 description 1
- XSUMTXIVYVXHQF-UHFFFAOYSA-N n-[4-(4-cyanophenyl)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)CC1 XSUMTXIVYVXHQF-UHFFFAOYSA-N 0.000 description 1
- VGTANERTDXIGKZ-UHFFFAOYSA-N n-[4-(4-fluorophenoxy)cyclohexyl]-5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(F)=CC=2)CC1 VGTANERTDXIGKZ-UHFFFAOYSA-N 0.000 description 1
- DDIKEHGCFSSELH-UHFFFAOYSA-N n-[4-(4-fluorophenoxy)cyclohexyl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(F)=CC=2)CC1 DDIKEHGCFSSELH-UHFFFAOYSA-N 0.000 description 1
- NOIUJGNQSASNRI-UHFFFAOYSA-N n-[4-(4-fluorophenoxy)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=CC(F)=CC=3)=CC=2)CC1 NOIUJGNQSASNRI-UHFFFAOYSA-N 0.000 description 1
- DDXGSXLONGRSHS-UHFFFAOYSA-N n-[4-[(4-cyanophenyl)methyl]cyclohexyl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=C(C=CC=2)C(=O)NC2CCC(CC=3C=CC(=CC=3)C#N)CC2)CC1 DDXGSXLONGRSHS-UHFFFAOYSA-N 0.000 description 1
- BPUSTKQLALECFR-UHFFFAOYSA-N n-[4-[(4-cyanophenyl)methylcarbamoyl]phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C(=O)NCC=2C=CC(=CC=2)C#N)CC1 BPUSTKQLALECFR-UHFFFAOYSA-N 0.000 description 1
- OWQAWPLCNSFMKM-UHFFFAOYSA-N n-[5-(4-cyanophenoxy)pyridin-2-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2N=CC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 OWQAWPLCNSFMKM-UHFFFAOYSA-N 0.000 description 1
- MHVPPJHUAXVIGF-UHFFFAOYSA-N n-[5-(4-cyanophenoxy)pyridin-2-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2N=CC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 MHVPPJHUAXVIGF-UHFFFAOYSA-N 0.000 description 1
- RVMRUZKLKWZPBU-UHFFFAOYSA-N n-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]-4-phenylbenzamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)=CC=2)CC1 RVMRUZKLKWZPBU-UHFFFAOYSA-N 0.000 description 1
- ASBBFNPPGCMMTH-UHFFFAOYSA-N n-[6-(3-cyanophenoxy)pyridin-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=C(C=CC=3)C#N)=CC=2)CC1 ASBBFNPPGCMMTH-UHFFFAOYSA-N 0.000 description 1
- GKRIJBBPXCVYRF-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)N=C1 GKRIJBBPXCVYRF-UHFFFAOYSA-N 0.000 description 1
- MAJDJUWLOQSGFM-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=C1 MAJDJUWLOQSGFM-UHFFFAOYSA-N 0.000 description 1
- NWALXLHJGKSUHI-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)S(=O)(=O)C=2C=CC(F)=CC=2)N=C1 NWALXLHJGKSUHI-UHFFFAOYSA-N 0.000 description 1
- GVYSRPMXFBVISQ-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C(C)=O)=CC=2)CC1 GVYSRPMXFBVISQ-UHFFFAOYSA-N 0.000 description 1
- UUWVSSXXHKEBGA-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)N=C1 UUWVSSXXHKEBGA-UHFFFAOYSA-N 0.000 description 1
- IDAXHXKLJMZMTG-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-[4-(dimethylcarbamoyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C(C)=O)=CC=2)CC1 IDAXHXKLJMZMTG-UHFFFAOYSA-N 0.000 description 1
- FGKOOCQTYBWAPY-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)-2-methylpyridin-3-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)C(C)=NC=1OC1=CC=C(C#N)C=C1 FGKOOCQTYBWAPY-UHFFFAOYSA-N 0.000 description 1
- YOZDAUSMDOLDJM-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)-2-methylpyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C(=NC(OC=3C=CC(=CC=3)C#N)=CC=2)C)CC1 YOZDAUSMDOLDJM-UHFFFAOYSA-N 0.000 description 1
- SXCVHBDVDRBZIC-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 SXCVHBDVDRBZIC-UHFFFAOYSA-N 0.000 description 1
- MBGUZCQMFZFQCG-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 MBGUZCQMFZFQCG-UHFFFAOYSA-N 0.000 description 1
- ZPVFVTXUAVUJPB-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 ZPVFVTXUAVUJPB-UHFFFAOYSA-N 0.000 description 1
- NMTSURTYCYXFAT-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 NMTSURTYCYXFAT-UHFFFAOYSA-N 0.000 description 1
- ZZTBEWMJLPGORM-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 ZZTBEWMJLPGORM-UHFFFAOYSA-N 0.000 description 1
- LFRYTBJZABLZSQ-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 LFRYTBJZABLZSQ-UHFFFAOYSA-N 0.000 description 1
- GEWONQLQWOVJJA-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(S(F)(F)(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 GEWONQLQWOVJJA-UHFFFAOYSA-N 0.000 description 1
- LFVWKMPSGSNUPO-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 LFVWKMPSGSNUPO-UHFFFAOYSA-N 0.000 description 1
- KQQWQTMZKXZLSA-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-methylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 KQQWQTMZKXZLSA-UHFFFAOYSA-N 0.000 description 1
- YYUWHTNNPRUOTQ-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC1CCN(C(=O)C=2N=CC(=NC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 YYUWHTNNPRUOTQ-UHFFFAOYSA-N 0.000 description 1
- BNYMQAJOSJXUFB-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 BNYMQAJOSJXUFB-UHFFFAOYSA-N 0.000 description 1
- GMARCTCAIUDFNX-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-morpholin-4-ylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCOCC2)C=N1 GMARCTCAIUDFNX-UHFFFAOYSA-N 0.000 description 1
- STPZXMKMNKFXAI-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)C=N1 STPZXMKMNKFXAI-UHFFFAOYSA-N 0.000 description 1
- XOCNQFFZQFEWHW-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 XOCNQFFZQFEWHW-UHFFFAOYSA-N 0.000 description 1
- FIRJMSDQQVUXBK-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CN=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)C=N1 FIRJMSDQQVUXBK-UHFFFAOYSA-N 0.000 description 1
- AECCUDKFJGLGKU-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)N=C1 AECCUDKFJGLGKU-UHFFFAOYSA-N 0.000 description 1
- HOYLOGISDOAXOM-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 HOYLOGISDOAXOM-UHFFFAOYSA-N 0.000 description 1
- CSSYEVQJDFHNJP-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-6-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)C=C1 CSSYEVQJDFHNJP-UHFFFAOYSA-N 0.000 description 1
- BPLWMEIZMICBAU-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(F)(F)(F)(F)F)N=C1 BPLWMEIZMICBAU-UHFFFAOYSA-N 0.000 description 1
- HSERFCLBNQCVPF-UHFFFAOYSA-N n-[6-(4-fluorophenyl)sulfonylpyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(=CC=2)S(=O)(=O)C=2C=CC(F)=CC=2)CC1 HSERFCLBNQCVPF-UHFFFAOYSA-N 0.000 description 1
- HIHGKUXVUVLGOQ-UHFFFAOYSA-N n-[6-[4-(dimethylcarbamoyl)phenoxy]pyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C(=O)N(C)C)=CC=2)CC1 HIHGKUXVUVLGOQ-UHFFFAOYSA-N 0.000 description 1
- LYNNCHNXFHBVFJ-UHFFFAOYSA-N n-benzyl-5-(4-benzylpiperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CC=CC=3)CC2)C=NC=1C(=O)NCC1=CC=CC=C1 LYNNCHNXFHBVFJ-UHFFFAOYSA-N 0.000 description 1
- SFBUXGKMWDVQSW-UHFFFAOYSA-N n-benzyl-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NCC=2C=CC=CC=2)CC1 SFBUXGKMWDVQSW-UHFFFAOYSA-N 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- KHQXBNWTAKPRMR-UHFFFAOYSA-N pyridazine-3,6-dicarboxamide Chemical compound NC(=O)C1=CC=C(C(N)=O)N=N1 KHQXBNWTAKPRMR-UHFFFAOYSA-N 0.000 description 1
- LEIAZUKOBVWTEH-UHFFFAOYSA-N pyridine-2,5-dicarboxamide Chemical compound NC(=O)C1=CC=C(C(N)=O)N=C1 LEIAZUKOBVWTEH-UHFFFAOYSA-N 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36892810P | 2010-07-29 | 2010-07-29 | |
| US61/368,928 | 2010-07-29 | ||
| PCT/US2011/046019 WO2012016217A1 (en) | 2010-07-29 | 2011-07-29 | Ampk-activating heterocyclic compounds and methods for using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532692A JP2013532692A (ja) | 2013-08-19 |
| JP2013532692A5 true JP2013532692A5 (https=) | 2014-09-04 |
| JP5889895B2 JP5889895B2 (ja) | 2016-03-22 |
Family
ID=44504240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013522013A Expired - Fee Related JP5889895B2 (ja) | 2010-07-29 | 2011-07-29 | Ampk活性化複素環化合物およびその使用方法 |
Country Status (24)
| Country | Link |
|---|---|
| US (8) | US8791136B2 (https=) |
| EP (1) | EP2598483B1 (https=) |
| JP (1) | JP5889895B2 (https=) |
| KR (1) | KR101764952B1 (https=) |
| CN (1) | CN103201267B (https=) |
| AU (1) | AU2011283684B2 (https=) |
| BR (1) | BR112013002112B1 (https=) |
| CA (1) | CA2806341C (https=) |
| CL (1) | CL2013000261A1 (https=) |
| DK (1) | DK2598483T3 (https=) |
| EA (1) | EA025611B1 (https=) |
| ES (1) | ES2823350T3 (https=) |
| HU (1) | HUE052110T2 (https=) |
| IL (1) | IL223856A (https=) |
| MX (1) | MX338707B (https=) |
| MY (1) | MY165584A (https=) |
| NZ (1) | NZ605692A (https=) |
| PE (1) | PE20130774A1 (https=) |
| PL (1) | PL2598483T3 (https=) |
| PT (1) | PT2598483T (https=) |
| SG (1) | SG186850A1 (https=) |
| UA (1) | UA112061C2 (https=) |
| WO (1) | WO2012016217A1 (https=) |
| ZA (2) | ZA201300374B (https=) |
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007079078A1 (en) | 2005-12-29 | 2007-07-12 | Bayer Schering Pharma Aktiengesellschaft | Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| BR112013002112B1 (pt) | 2010-07-29 | 2021-04-06 | Rigel Pharmaceuticals, Inc. | Composto, composição farmacêutica, e, uso de um composto, ou de um respectivo sal farmaceuticamente aceitável, ou de uma composição |
| PL2763979T3 (pl) | 2011-10-07 | 2019-06-28 | Takeda Pharmaceutical Company Limited | Związki 1-arylokarbonyl-4-oksy-piperydynowe użyteczne do leczenia chorób neurodegeneracyjnych |
| US9409884B2 (en) | 2012-02-01 | 2016-08-09 | Rigel Pharmaceuticals, Inc. | 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| US9126950B2 (en) | 2012-12-21 | 2015-09-08 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
| JP6437452B2 (ja) | 2013-01-14 | 2018-12-12 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Pimキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物 |
| RS60244B1 (sr) | 2013-01-15 | 2020-06-30 | Incyte Holdings Corp | Jedinjenja tiazolkarboksamida i piridinkarboksamida korisna kao inhibitori pim kinaze |
| TWI647227B (zh) | 2013-02-28 | 2019-01-11 | 日商安斯泰來製藥股份有限公司 | 2-醯胺噻唑衍生物或其鹽 |
| ES2864862T3 (es) | 2013-03-12 | 2021-10-14 | Celltaxis Llc | Métodos de inhibición de la leucotrieno A4 hidrolasa |
| SG10201707409PA (en) | 2013-03-13 | 2017-10-30 | Forma Therapeutics Inc | Novel compounds and compositions for inhibition of fasn |
| MX2015011677A (es) * | 2013-03-14 | 2016-07-08 | Celtaxsys Inc | Inhibidores de leucotrieno a4 hidrolasa. |
| WO2014152536A2 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
| RU2678196C2 (ru) | 2013-03-14 | 2019-01-24 | Селтакссис, Инк. | Производные 2-фениламино-3-цианопиразоло[1,5-а]пиримидина, полезные в качестве ингибитора лейкотриен-a4-гидролазы |
| JP6064062B2 (ja) | 2013-03-15 | 2017-01-18 | ファイザー・インク | Ampkを活性化させるインダゾール化合物 |
| EA028545B1 (ru) * | 2013-06-10 | 2017-11-30 | Астеллас Фарма Инк. | Бициклическое азотсодержащее ароматическое гетероциклическое амидное соединение |
| JP6378759B2 (ja) | 2013-07-02 | 2018-08-22 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | Sumo活性化酵素阻害剤として有用なヘテロアリール化合物 |
| CN105658653A (zh) | 2013-08-23 | 2016-06-08 | 因赛特公司 | 可用作pim激酶抑制剂的呋喃并-和噻吩并-吡啶甲酰胺化合物 |
| WO2015048547A2 (en) | 2013-09-26 | 2015-04-02 | Rigel Pharmaceuticals, Inc. | Methods for using and biomarkers for ampk-activating compounds |
| US20160214967A1 (en) * | 2013-09-30 | 2016-07-28 | The University Of Tokyo | Activator of adiponectin receptor |
| CN105683188B (zh) | 2013-10-25 | 2018-02-09 | 诺华股份有限公司 | 作为fgfr4抑制剂的稠环二环吡啶基衍生物 |
| US9415049B2 (en) | 2013-12-20 | 2016-08-16 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
| JP6523303B2 (ja) | 2014-01-17 | 2019-05-29 | ノバルティス アーゲー | Shp2の活性を阻害するための1−ピリダジン/トリアジン−3−イル−ピペラジン/ピペリジン/ピロリジン誘導体およびその組成物 |
| CN105899493B (zh) | 2014-01-17 | 2019-03-29 | 诺华股份有限公司 | 用于抑制shp2活性的1-(三嗪-3-基/哒嗪-3-基)-哌(-嗪)啶衍生物及其组合物 |
| JO3517B1 (ar) | 2014-01-17 | 2020-07-05 | Novartis Ag | ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2 |
| WO2015131773A1 (zh) * | 2014-03-06 | 2015-09-11 | 上海海雁医药科技有限公司 | 作为食欲素受体拮抗剂的哌啶衍生物 |
| EA031866B1 (ru) * | 2014-06-06 | 2019-03-29 | Астеллас Фарма Инк. | Производное 2-ациламинотиазола или его соль |
| SG11201610476VA (en) | 2014-07-01 | 2017-01-27 | Millennium Pharm Inc | Heteroaryl compounds useful as inhibitors of sumo activating enzyme |
| WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| BR112017003901A2 (pt) | 2014-08-26 | 2017-12-12 | Astellas Pharma Inc | derivado de 2-aminotiazola ou sal do mesmo |
| JP6585167B2 (ja) | 2014-10-03 | 2019-10-02 | ノバルティス アーゲー | Fgfr4阻害剤としての縮環二環式ピリジル誘導体の使用 |
| BR112017005104B1 (pt) | 2014-10-10 | 2022-08-23 | Pulmocide Limited | Derivados de 5,6-di-hidro-4h-benzotieno-[2,3-d]azepina, seus usos, composição farmacêutica e processo para a preparação dos mesmos |
| KR20200087273A (ko) | 2014-10-24 | 2020-07-20 | 란도스 바이오파마, 인크. | 란티오닌 합성효소 c-유사 2-계 치료제 |
| JP6694886B2 (ja) | 2014-12-18 | 2020-05-20 | プルモシデ リミテド | 4,5−ジヒドロ−6H−チエノ[3,2−d]ベンゾアゼピン誘導体及び呼吸器合胞体ウイルス(RSV)感染を治療するためのその使用 |
| US9802917B2 (en) | 2015-03-25 | 2017-10-31 | Novartis Ag | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide |
| WO2016196244A1 (en) | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
| CN112625028B (zh) | 2015-06-19 | 2024-10-29 | 诺华股份有限公司 | 用于抑制shp2活性的化合物和组合物 |
| ES2824576T3 (es) | 2015-06-19 | 2021-05-12 | Novartis Ag | Compuestos y composiciones para inhibir la actividad de SHP2 |
| ES2741746T3 (es) | 2015-06-19 | 2020-02-12 | Novartis Ag | Compuestos y composiciones para inhibir la actividad de SHP2 |
| TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Pim激酶抑制劑之鹽 |
| US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
| EP3365334B1 (en) | 2015-10-21 | 2024-07-17 | Otsuka Pharmaceutical Co., Ltd. | Benzolactam compounds as protein kinase inhibitors |
| ES2775449T3 (es) | 2016-01-22 | 2020-07-27 | Janssen Pharmaceutica Nv | Nuevos derivados de cianoindolina sustituida como inhibidores de nik |
| EP3405464B1 (en) | 2016-01-22 | 2019-12-04 | Janssen Pharmaceutica NV | New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors |
| EA202092441A1 (ru) | 2016-06-07 | 2021-05-21 | Джакобио Фармасьютикалс Ко., Лтд. | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 |
| MX383856B (es) | 2016-06-14 | 2025-03-14 | Novartis Ag | Compuestos y composiciones para inhibir la actividad de shp2. |
| WO2018002217A1 (en) | 2016-06-30 | 2018-01-04 | Janssen Pharmaceutica Nv | Heteroaromatic derivatives as nik inhibitors |
| ES2837157T3 (es) | 2016-06-30 | 2021-06-29 | Janssen Pharmaceutica Nv | Derivados de cianoindolina como inhibidores de NIK |
| EP3484876A1 (en) | 2016-07-14 | 2019-05-22 | Pfizer Inc | Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme |
| US11970486B2 (en) | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| EA201991650A1 (ru) | 2017-01-06 | 2020-01-20 | Юманити Терапьютикс, Инк. | Способы лечения неврологических расстройств |
| US20190343836A1 (en) | 2017-01-10 | 2019-11-14 | Novartis Ag | Pharmaceutical combination comprising an alk inhibitor and a shp2 inhibitor |
| BR112019019109B1 (pt) * | 2017-03-15 | 2023-11-07 | Lunella Biotech, Inc | Compostos mitorriboscina, composição farmacêutica compreendendo os mesmos, e seus usos direcionados para células cancerosas, bactérias e levedura patogênica |
| KR20240026521A (ko) | 2017-03-23 | 2024-02-28 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| GB201706327D0 (en) | 2017-04-20 | 2017-06-07 | Otsuka Pharma Co Ltd | A pharmaceutical compound |
| JOP20190245A1 (ar) | 2017-04-20 | 2019-10-15 | Novartis Ag | أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط |
| JP7312749B2 (ja) | 2017-08-04 | 2023-07-21 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングをモジュレートする方法および組成物 |
| BR112020003725A2 (pt) | 2017-10-06 | 2020-11-03 | Forma Therapeutics, Inc. | inibição da peptidase 30 específica de ubiquitina |
| CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| SG10202011632RA (en) | 2017-10-27 | 2021-01-28 | Boehringer Ingelheim Int | Pyridine carbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors |
| AR113922A1 (es) | 2017-12-08 | 2020-07-01 | Incyte Corp | Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas |
| WO2019161224A1 (en) | 2018-02-15 | 2019-08-22 | GiraFpharma LLC | Heterocyclic compounds as kinase inhibitors |
| BR112020019191A2 (pt) | 2018-03-23 | 2021-01-05 | Yumanity Therapeutics, Inc. | Compostos e seus usos |
| JP7449242B2 (ja) | 2018-05-17 | 2024-03-13 | フォーマ セラピューティクス,インコーポレイテッド | ユビキチン特異的ペプチダーゼ30(usp30)阻害剤として有用な縮合二環化合物 |
| EP3801559B1 (en) | 2018-05-31 | 2025-01-01 | Celltaxis, LLC | Method of reducing pulmonary exacerbations in respiratory disease patients |
| US12030875B2 (en) | 2018-09-07 | 2024-07-09 | PIC Therapeutics, Inc. | EIF4E inhibitors and uses thereof |
| JP7542538B2 (ja) | 2018-09-18 | 2024-08-30 | ニカング セラピューティクス, インコーポレイテッド | Srcホモロジー-2ホスファターゼ阻害剤としての縮合三環式環誘導体 |
| CN112839935A (zh) | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
| AR116566A1 (es) | 2018-10-03 | 2021-05-19 | Novartis Ag | Administración sostenida de polipéptidos similares a la angiopoyetina 3 |
| LT3860989T (lt) | 2018-10-05 | 2023-06-12 | Forma Therapeutics, Inc. | Sulieti pirolinai, kurie veikia kaip ubikvitinui specifinės proteazės 30 (ups30) inhibitoriai |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
| WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| BR112021008995A2 (pt) | 2018-12-26 | 2021-08-10 | Raqualia Pharma Inc. | derivados heterocíclicos como bloqueadores de nav1.7 e nav1.8 |
| MX2021008903A (es) | 2019-01-24 | 2021-11-04 | Yumanity Therapeutics Inc | Compuestos y usos de los mismos. |
| WO2020163405A1 (en) | 2019-02-05 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| JP7551629B2 (ja) | 2019-02-05 | 2024-09-17 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| JP7603594B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| JP7603595B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| MX2021013531A (es) | 2019-05-05 | 2022-02-11 | Qilu Regor Therapeutics Inc | Inhibidores de cdk. |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| BR112022002387A2 (pt) | 2019-12-20 | 2022-09-06 | Landos Biopharma Inc | Composto da fórmula z-y-q-y' ou um sal ou éster farmaceuticamente aceitável do mesmo |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| US12234578B2 (en) | 2020-01-29 | 2025-02-25 | Wisconsin Alumni Research Foundation | Tannin composite fibers |
| AU2021230289A1 (en) | 2020-03-03 | 2022-09-29 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| WO2021236617A1 (en) | 2020-05-19 | 2021-11-25 | Kallyope, Inc. | Ampk activators |
| CA3183575A1 (en) | 2020-06-26 | 2021-12-30 | Iyassu Sebhat | Ampk activators |
| CA3188340A1 (en) | 2020-08-13 | 2022-02-17 | Boehringer Ingelheim International Gmbh | Treatment of cognitive impairement associated with schizophrenia |
| EP4221700A1 (en) | 2020-09-30 | 2023-08-09 | Bioverativ Therapeutics Inc. | Ampk activators and methods of use thereof |
| CA3195702A1 (en) | 2020-10-13 | 2022-04-21 | Boehringer Ingelheim International Gmbh | Process of reworking |
| CR20230325A (es) | 2020-12-30 | 2023-12-11 | Tyra Biosciences Inc | Compuestos de indazol como inhibidores de cinasas |
| JP2024534127A (ja) | 2021-08-25 | 2024-09-18 | ピク セラピューティクス, インコーポレイテッド | eIF4E阻害剤及びその使用 |
| US12157732B2 (en) | 2021-08-25 | 2024-12-03 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| WO2023107705A1 (en) | 2021-12-10 | 2023-06-15 | Incyte Corporation | Bicyclic amines as cdk12 inhibitors |
| WO2024006297A1 (en) * | 2022-06-28 | 2024-01-04 | Modulation Therapeutics, Inc. | Scd1 inhibitors for treating liver disease |
| WO2025018978A1 (en) * | 2023-07-14 | 2025-01-23 | Modulation Therapeutics, Inc. | Scd1 inhibitors for treating hematolymphoid neoplasms |
| WO2025217513A1 (en) * | 2024-04-11 | 2025-10-16 | The Trustees Of Indiana University | Activation of plcg2 as a therapeutic strategy for the treatment of alzheimer's disease |
| CN119039234A (zh) * | 2024-08-19 | 2024-11-29 | 中国药科大学 | 一种哒嗪酰胺类化合物及其制备方法与应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005014571A1 (en) | 2003-07-18 | 2005-02-17 | Glaxo Group Limited | Substituted piperidines as histamine h3 receptor ligands |
| AU2004274309B2 (en) * | 2003-09-22 | 2010-04-08 | Msd K.K. | Novel piperidine derivative |
| CA2549009A1 (en) | 2003-12-12 | 2005-07-07 | Eli Lilly And Company | Opioid receptor antagonists |
| WO2007098086A2 (en) | 2006-02-17 | 2007-08-30 | Avalon Pharmaceuticals | Hydroxypiperidine derivatives and uses thereof |
| DE602006021591D1 (de) * | 2006-12-11 | 2011-06-09 | Genetics Co Inc | Aromatische 1,4-DI-Carboxylamide und deren Verwendung |
| CA2674237C (en) | 2006-12-28 | 2015-11-24 | Rigel Pharmaceuticals, Inc. | N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| CA2697077C (en) * | 2007-08-22 | 2012-10-16 | Irm Llc | 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| BRPI0820171B8 (pt) * | 2007-11-16 | 2021-05-25 | Rigel Pharmaceuticals Inc | compostos de carboxamida, sulfonamida e amina para distúrbios metabólicos, composição farmacêutica, e, uso dos mesmos |
| CA2707047C (en) * | 2007-12-12 | 2017-11-28 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| MX2010011288A (es) * | 2008-04-23 | 2010-11-09 | Rigel Pharmaceuticals Inc | Compuestos de carboxamida para el tratamiento de trastornos metabolicos. |
| CN102365275B (zh) * | 2009-01-28 | 2014-09-24 | 里格尔药品股份有限公司 | 羧酰胺化合物及其使用方法 |
| AU2010241742A1 (en) * | 2009-04-27 | 2011-11-17 | Elan Pharmaceuticals, Inc. | Pyridinone antagonists of alpha-4 integrins |
| CA2759843A1 (en) | 2009-05-08 | 2010-11-10 | Pfizer Inc. | Gpr 119 modulators |
| BR112013002112B1 (pt) | 2010-07-29 | 2021-04-06 | Rigel Pharmaceuticals, Inc. | Composto, composição farmacêutica, e, uso de um composto, ou de um respectivo sal farmaceuticamente aceitável, ou de uma composição |
| US9409884B2 (en) * | 2012-02-01 | 2016-08-09 | Rigel Pharmaceuticals, Inc. | 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them |
-
2011
- 2011-07-29 BR BR112013002112-8A patent/BR112013002112B1/pt not_active IP Right Cessation
- 2011-07-29 DK DK11746709.2T patent/DK2598483T3/da active
- 2011-07-29 WO PCT/US2011/046019 patent/WO2012016217A1/en not_active Ceased
- 2011-07-29 PE PE2013000118A patent/PE20130774A1/es active IP Right Grant
- 2011-07-29 HU HUE11746709A patent/HUE052110T2/hu unknown
- 2011-07-29 PL PL11746709T patent/PL2598483T3/pl unknown
- 2011-07-29 AU AU2011283684A patent/AU2011283684B2/en not_active Ceased
- 2011-07-29 EP EP11746709.2A patent/EP2598483B1/en active Active
- 2011-07-29 EA EA201390184A patent/EA025611B1/ru not_active IP Right Cessation
- 2011-07-29 MX MX2013000575A patent/MX338707B/es active IP Right Grant
- 2011-07-29 CN CN201180047484.XA patent/CN103201267B/zh not_active Expired - Fee Related
- 2011-07-29 NZ NZ605692A patent/NZ605692A/en not_active IP Right Cessation
- 2011-07-29 PT PT117467092T patent/PT2598483T/pt unknown
- 2011-07-29 KR KR1020137005054A patent/KR101764952B1/ko not_active Expired - Fee Related
- 2011-07-29 US US13/194,810 patent/US8791136B2/en active Active
- 2011-07-29 ES ES11746709T patent/ES2823350T3/es active Active
- 2011-07-29 JP JP2013522013A patent/JP5889895B2/ja not_active Expired - Fee Related
- 2011-07-29 SG SG2012095964A patent/SG186850A1/en unknown
- 2011-07-29 UA UAA201302459A patent/UA112061C2/uk unknown
- 2011-07-29 CA CA2806341A patent/CA2806341C/en active Active
- 2011-07-29 MY MYPI2013000077A patent/MY165584A/en unknown
-
2012
- 2012-12-25 IL IL223856A patent/IL223856A/en active IP Right Grant
-
2013
- 2013-01-15 ZA ZA2013/00374A patent/ZA201300374B/en unknown
- 2013-01-28 CL CL2013000261A patent/CL2013000261A1/es unknown
- 2013-03-13 US US13/800,986 patent/US8809370B2/en active Active
- 2013-03-13 US US13/801,064 patent/US8980921B2/en active Active
- 2013-03-13 US US13/801,030 patent/US8987303B2/en active Active
-
2014
- 2014-03-13 ZA ZA2014/01833A patent/ZA201401833B/en unknown
- 2014-07-08 US US14/325,766 patent/US9266856B2/en not_active Expired - Fee Related
-
2016
- 2016-01-12 US US14/993,936 patent/US9663496B2/en not_active Expired - Fee Related
-
2017
- 2017-05-23 US US15/603,023 patent/US10377742B2/en active Active
-
2019
- 2019-06-25 US US16/451,613 patent/US10941134B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532692A5 (https=) | ||
| CN117242067B (zh) | 作为glp1r激动剂的新型芳醚取代杂环类化合物 | |
| JP5889895B2 (ja) | Ampk活性化複素環化合物およびその使用方法 | |
| JP5432718B2 (ja) | ピロール化合物 | |
| EP3101015B1 (en) | Heterocyclic sulfonamide derivative and medicine comprising same | |
| JP4035559B1 (ja) | 酸分泌抑制薬としての1−ヘテロシクリルスルホニル、2−アミノメチル、5−(ヘテロ−)アリール置換1−h−ピロール誘導体 | |
| US20130029962A1 (en) | Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands | |
| JP2011506480A5 (https=) | ||
| JP2011503210A5 (https=) | ||
| JP2010514788A5 (https=) | ||
| KR20260042557A (ko) | 항암 및 항-증식 활성을 나타내는 2-아미노피리미딘-6-온 및 유사체 | |
| US20130029961A1 (en) | Substituted Heterocyclic Aza Compounds | |
| JP2008516902A5 (https=) | ||
| JP2008509955A5 (https=) | ||
| JP2012516349A5 (https=) | ||
| CN103153957B (zh) | N-吡啶-3-基或n-吡嗪-2-基甲酰胺类 | |
| EP2448584B1 (en) | Substituted 4-hydroxypyrimidine-5-carboxamides | |
| EA052585B1 (ru) | Новые гетероциклические соединения, замещенные простым ариловым эфиром, в качестве агонистов glp1r | |
| WO2025222008A1 (en) | Glucagon receptor agonists and their use as therapies | |
| JP2007516290A5 (https=) | ||
| RU2376295C2 (ru) | Производные пиримидинона и фармацевтическая композиция на их основе, обладающая свойствами ингибитора нейтрофильной эластазы человека | |
| TW201311664A (zh) | 以含被取代吡唑芳環之羧醯胺與尿素衍生物做為類香草素受體之配位體 |